CA3162676A1 - Method for detecting hydrogen peroxide resistance in crustaceans - Google Patents
Method for detecting hydrogen peroxide resistance in crustaceans Download PDFInfo
- Publication number
- CA3162676A1 CA3162676A1 CA3162676A CA3162676A CA3162676A1 CA 3162676 A1 CA3162676 A1 CA 3162676A1 CA 3162676 A CA3162676 A CA 3162676A CA 3162676 A CA3162676 A CA 3162676A CA 3162676 A1 CA3162676 A1 CA 3162676A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- sea lice
- lice
- protein
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 138
- 238000000034 method Methods 0.000 title claims abstract description 116
- 241000238424 Crustacea Species 0.000 title abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 285
- 241001674048 Phthiraptera Species 0.000 claims abstract description 238
- 230000014509 gene expression Effects 0.000 claims abstract description 199
- 241001247234 Lepeophtheirus salmonis Species 0.000 claims abstract description 52
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 36
- 238000001514 detection method Methods 0.000 claims abstract description 27
- 241001611004 Caligus rogercresseyi Species 0.000 claims abstract description 17
- 102100031857 Endoplasmic reticulum resident protein 29 Human genes 0.000 claims description 102
- 101710113964 Endoplasmic reticulum resident protein 29 Proteins 0.000 claims description 102
- 108010053835 Catalase Proteins 0.000 claims description 93
- 102000004169 proteins and genes Human genes 0.000 claims description 93
- 102000016938 Catalase Human genes 0.000 claims description 81
- 102000016560 Aquaglyceroporins Human genes 0.000 claims description 59
- 108010092667 Aquaglyceroporins Proteins 0.000 claims description 59
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 56
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 56
- 239000012634 fragment Substances 0.000 claims description 31
- 241001611011 Caligus Species 0.000 claims description 27
- 229910001868 water Inorganic materials 0.000 claims description 27
- 241000251468 Actinopterygii Species 0.000 claims description 26
- 108020004414 DNA Proteins 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 241001405819 Caligus elongatus Species 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 20
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 230000000295 complement effect Effects 0.000 claims description 12
- 102000053602 DNA Human genes 0.000 claims description 10
- 238000000338 in vitro Methods 0.000 claims description 5
- 101100238304 Mus musculus Morc1 gene Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000013615 primer Substances 0.000 description 40
- 238000011282 treatment Methods 0.000 description 27
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 26
- 108010063290 Aquaporins Proteins 0.000 description 25
- 235000019688 fish Nutrition 0.000 description 25
- 102000010637 Aquaporins Human genes 0.000 description 24
- 239000000523 sample Substances 0.000 description 23
- 150000007523 nucleic acids Chemical group 0.000 description 21
- 244000045947 parasite Species 0.000 description 21
- 238000003559 RNA-seq method Methods 0.000 description 20
- 238000003753 real-time PCR Methods 0.000 description 18
- 229940079593 drug Drugs 0.000 description 17
- 239000003814 drug Substances 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 17
- 230000035945 sensitivity Effects 0.000 description 16
- 241000972773 Aulopiformes Species 0.000 description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 description 15
- 230000001105 regulatory effect Effects 0.000 description 15
- 235000019515 salmon Nutrition 0.000 description 15
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 14
- 239000002751 oligonucleotide probe Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000004166 bioassay Methods 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 12
- 238000009360 aquaculture Methods 0.000 description 11
- 244000144974 aquaculture Species 0.000 description 11
- 241000239250 Copepoda Species 0.000 description 10
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 230000032258 transport Effects 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 7
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108091006146 Channels Proteins 0.000 description 5
- 239000003155 DNA primer Substances 0.000 description 5
- 239000005892 Deltamethrin Substances 0.000 description 5
- 206010059866 Drug resistance Diseases 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 5
- 229960002483 decamethrin Drugs 0.000 description 5
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000009313 farming Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 239000002987 primer (paints) Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 241000222722 Leishmania <genus> Species 0.000 description 4
- 241000277263 Salmo Species 0.000 description 4
- 241000277331 Salmonidae Species 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 238000010200 validation analysis Methods 0.000 description 4
- 241001247232 Caligidae Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001247233 Lepeophtheirus Species 0.000 description 3
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 3
- 101710166115 Mitogen-activated protein kinase 2 Proteins 0.000 description 3
- 102100031156 Prohibitin-2 Human genes 0.000 description 3
- 101710098058 Prohibitin-2 Proteins 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000002869 basic local alignment search tool Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000010432 diamond Substances 0.000 description 3
- 230000003828 downregulation Effects 0.000 description 3
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 description 3
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000004920 integrated pest control Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 102000004888 Aquaporin 1 Human genes 0.000 description 2
- 108090001004 Aquaporin 1 Proteins 0.000 description 2
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- 241000238421 Arthropoda Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 102100034349 Integrase Human genes 0.000 description 2
- JCYZMTMYPZHVBF-UHFFFAOYSA-N Melarsoprol Chemical compound NC1=NC(N)=NC(NC=2C=CC(=CC=2)[As]2SC(CO)CS2)=N1 JCYZMTMYPZHVBF-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000133262 Nauplius Species 0.000 description 2
- 102100023306 Nesprin-1 Human genes 0.000 description 2
- 101710202335 Nesprin-1 Proteins 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 241000277275 Oncorhynchus mykiss Species 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 241000191896 Rana sylvatica Species 0.000 description 2
- 241000242680 Schistosoma mansoni Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 101710100170 Unknown protein Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 208000010824 fish disease Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000012248 genetic selection Methods 0.000 description 2
- 244000000013 helminth Species 0.000 description 2
- -1 hydroxyl radicals Chemical class 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 229960001728 melarsoprol Drugs 0.000 description 2
- 239000003147 molecular marker Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 2
- 229960004448 pentamidine Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008261 resistance mechanism Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 101150111620 AQP1 gene Proteins 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241001148083 Aeromonas salmonicida subsp. salmonicida Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 108010036221 Aquaporin 2 Proteins 0.000 description 1
- 102000011899 Aquaporin 2 Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 description 1
- 101100352919 Caenorhabditis elegans ppm-2 gene Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241001647146 Crangon septemspinosa Species 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 101710138607 DNA polymerase delta subunit 3 Proteins 0.000 description 1
- 102100020782 DNA polymerase delta subunit 3 Human genes 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 101100192865 Drosophila melanogaster GlyP gene Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 108010036164 Glutathione synthase Proteins 0.000 description 1
- 102100034294 Glutathione synthetase Human genes 0.000 description 1
- 108091070965 Group 1 family Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000238071 Homarus americanus Species 0.000 description 1
- 101000730643 Homo sapiens Zinc finger protein PLAGL1 Proteins 0.000 description 1
- 241000269951 Labridae Species 0.000 description 1
- 241000222732 Leishmania major Species 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 102220483274 Metabotropic glutamate receptor 8_F362Y_mutation Human genes 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000238550 Penaeidae Species 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241001517016 Photobacterium damselae Species 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 235000014548 Rubus moluccanus Nutrition 0.000 description 1
- 241000277289 Salmo salar Species 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000015107 ale Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- WBTCZEPSIIFINA-MSFWTACDSA-J dipotassium;antimony(3+);(2r,3r)-2,3-dioxidobutanedioate;trihydrate Chemical compound O.O.O.[K+].[K+].[Sb+3].[Sb+3].[O-]C(=O)[C@H]([O-])[C@@H]([O-])C([O-])=O.[O-]C(=O)[C@H]([O-])[C@@H]([O-])C([O-])=O WBTCZEPSIIFINA-MSFWTACDSA-J 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 230000001909 effect on DNA Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 229930192878 garvin Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 101150073223 hisat gene Proteins 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000028454 lice infestation Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- 150000002738 metalloids Chemical class 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000010149 post-hoc-test Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000004632 predicting treatment efficacy Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000012865 response to insecticide Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000012418 validation experiment Methods 0.000 description 1
- 230000007279 water homeostasis Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a method for detecting whether or not crustaceans, in particular sea lice, such as Lepeophtheirus salmonis and Caligusrogercresseyi is resistant towards hydrogen peroxide (H2O2). In particular, the method of the invention relates to the detection of the expression level of genes found to be either upregulated or downregulated in sea lice resistant towards H2O2. The present invention furthermore relates to oligonucleotide sequences and kits comprising oligonucleotide sequences useful in the method of the present invention.
Description
TITLE: Method for detecting hydrogen peroxide resistance in crustaceans Field of the invention The present invention relates to a method for detecting whether or not crustaceans, in particular sea lice, such as Lepeophtheirus salmonis and Caligus rogereresseyi is resistant towards hydrogen peroxide (f1/0/). In particular, the method of the invention relates to the detection of the expression level of genes found to be either upregulated or downregulated in sea lice resistant towards H202. The present invention furthermore relates to oligonucicotidc sequences and kits useful in thc method of the present invention.
Background of the invention Sea lice are naturally occurring marine ectoparasites that attach to the skin and feed on the mucus, blood and surface tissues of salmon and other species of fish. Sea lice (Lepeophtheirus salmonis and Caligus spp.) arc the major pathogens affecting global salmon farming industry and have a significant impact in many areas. The annual loss was for the global salmon farming industry were estimated to Ã300 million in 2009 (Costello M.
J. (2009), The global economic cost of sea lice to the salmonid farming industry. Journal of Fish Diseases. 32. 115 118), and in 2013 it was estimated to USD 300 mill in Chile alone (Augusti C., Bravo S., Contreras G., Bakke M.J., Helgesen K.O., Winkler C., Silva M.T., Mendosa J., Horsberg T.E. (2016), Sensitivity assessment of (Vigils rogereresseyi to anti-louse chemicals in relation to treatment efficacy in Chilean salmonid farms.
Aquaculture 458, 195-205).
Thus, aquaculture industry relays heavily on a few chemotherapeutants for sea lice control.
Emerging resistance development to these drugs increase the necessity to develop new treatment methods (biological, prophylactic and drugs) and tools to avoid increased loss due to sea lice and to ensure a sustainable salmon farming industry in the future. Control measures have relied upon a limited number of chemothcrapeutants since the 1970s.
Parasite resistance and reduced efficacy have now been reported for the majority of these compounds (Sevatdal S., et al. (2005), "Monitoring of the sensitivity of sea lice (Lepeophtheirus salmonis) to pyrethroids in Norway, Ireland and Scotland using bioassays and probit modeling)", Aquaculture 244, 19-27). A successful integrated louse-management strategy requires free access to a range of effective, chemically unrelated active ingredients deployed according to current best practice. Over-reliance on a limited number of products will lead, inevitably to resistance, which is difficult to counter.
Although various chemotherapeutants have been in use in the aquaculture industry for more than 35 years, it is only during the last 20 years that such use has been part of some kind of integrated pest management (IPM) system. Management practices include coordinated salmon production within a defined area, use of single year class of fish, limited production period, fallowing, coordinated restocking, use of wrasse, synchronized treatments during the winter and targeting female lice to reduce the impact of settlement during the spring (Pike A., Wadsworth S. L., (2000), -Sea Lice: A review.
Advances in Parasitology", Academic Press. 44. 232-337).
Background of the invention Sea lice are naturally occurring marine ectoparasites that attach to the skin and feed on the mucus, blood and surface tissues of salmon and other species of fish. Sea lice (Lepeophtheirus salmonis and Caligus spp.) arc the major pathogens affecting global salmon farming industry and have a significant impact in many areas. The annual loss was for the global salmon farming industry were estimated to Ã300 million in 2009 (Costello M.
J. (2009), The global economic cost of sea lice to the salmonid farming industry. Journal of Fish Diseases. 32. 115 118), and in 2013 it was estimated to USD 300 mill in Chile alone (Augusti C., Bravo S., Contreras G., Bakke M.J., Helgesen K.O., Winkler C., Silva M.T., Mendosa J., Horsberg T.E. (2016), Sensitivity assessment of (Vigils rogereresseyi to anti-louse chemicals in relation to treatment efficacy in Chilean salmonid farms.
Aquaculture 458, 195-205).
Thus, aquaculture industry relays heavily on a few chemotherapeutants for sea lice control.
Emerging resistance development to these drugs increase the necessity to develop new treatment methods (biological, prophylactic and drugs) and tools to avoid increased loss due to sea lice and to ensure a sustainable salmon farming industry in the future. Control measures have relied upon a limited number of chemothcrapeutants since the 1970s.
Parasite resistance and reduced efficacy have now been reported for the majority of these compounds (Sevatdal S., et al. (2005), "Monitoring of the sensitivity of sea lice (Lepeophtheirus salmonis) to pyrethroids in Norway, Ireland and Scotland using bioassays and probit modeling)", Aquaculture 244, 19-27). A successful integrated louse-management strategy requires free access to a range of effective, chemically unrelated active ingredients deployed according to current best practice. Over-reliance on a limited number of products will lead, inevitably to resistance, which is difficult to counter.
Although various chemotherapeutants have been in use in the aquaculture industry for more than 35 years, it is only during the last 20 years that such use has been part of some kind of integrated pest management (IPM) system. Management practices include coordinated salmon production within a defined area, use of single year class of fish, limited production period, fallowing, coordinated restocking, use of wrasse, synchronized treatments during the winter and targeting female lice to reduce the impact of settlement during the spring (Pike A., Wadsworth S. L., (2000), -Sea Lice: A review.
Advances in Parasitology", Academic Press. 44. 232-337).
2 Further tools are required to progress towards a true IPM-system common to other forms of food production. One key to succeeding with an IPM is to develop tools for the management of resistance to the medicines in use (Brook K. (2009), "Considerations in developing an integrated pest management program for control of sea lice on farmed salmon in Pacific Canada-, Journal of Fish Diseases. 32, 59-73). Bioassays that require comprehensive numbers of parasites, equipment and labor were used to monitor sensitivity.
However, these methods showed low sensitivity, and had limitations when comparing resistance in different regions, as well as predicting treatment efficacy. Resistance mechanisms can be identified in some cases, and molecular methods, with high precision, high -throughput potential and reduced total cost (Aaen et al., 2015, "Drug resistance in sea lice: a threat to salmonid aquaculture". Trends in Parasitology, Vol 31, No. 2). Resistance towards organophosphates has been linked to Phe362Tyr mutation in the AChE coding gene. For pyrethroids several factors are likely to be involved in resistance, cytochrome P450 is involved in the detoxification of pyrethroids, as well as biomarkers in the mitochondrial DNA (Bakke et al., 2018,"Deltamethrin resistance in the salmon louse.
Lepeophtheirus salmonis (Kroyer): Maternal inheritance and reduced apoptosis." Scientific Reports, Vol. 8, 8450). Using these genes, it was demonstrated that medicinal treatments drive genetic selection towards a more resistant salmon lice population within a very short time span if there is no influx of sensitive genotypes (Jensen et al., 2017, "A selection study on laboratory-designed population of salmon lice (Lepeophtherius salrnonis) using organophosphatc and pyrcthroid pesticides", PLOS one12(5)e0178086).
PCR based methods for detection of resistance genes have been published for azamethiphos (EP 3 033 433 A 1 ), pyrethroids (EP 3 030 673 Al, EP 3 030 674 Al) as well as the catalase gene for hydrogen peroxide resistance (EP 3 164 502 B1).
Hydrogen peroxide has been demonstrated to be the least harmful to non-target organisms, highly effective against certain stages of louse development and most environmentally responsible (Burridge, L. 2013, -A review of potential environmental risks associated with the use of pesticides to treat Atlantic salmon against infestations of sea lice in southwest New Brunswick, Canada, DFO Can. Sci. Advis. Sec. Res. Doc. 2013/050. iv + 25 p). Interox Paraniove 50 is a commercially available hydrogen peroxide product for the treatment of sea lice. It contains 50%
hydrogen peroxide.
Hydrogen peroxide is only efficacious on post-chalimus stages of sea lice; it must be used in conjunction with other pest management techniques to maximize treatment benefits. There are conflicting results regarding viability of sea lice post treatment as well as the ability of lice re-infection. Because there are no techniques currently developed to remove sea lice from a tarp treatment, timing of treatment to target post-chalimus stage lice is essential. Recent studies of egg viability and nauplii survival post-treatment do indicate that nauplii survival reaches 0 within days of hatch.
Hydrogen peroxide breaks down readily into water and is considered the anti-louse treatment with least environmental risk. Recent studies comparing the effects of Interox Paramove 50, Salmosan , and AlphaMax on American lobster, mysid shrimp and sand shrimp showed that
However, these methods showed low sensitivity, and had limitations when comparing resistance in different regions, as well as predicting treatment efficacy. Resistance mechanisms can be identified in some cases, and molecular methods, with high precision, high -throughput potential and reduced total cost (Aaen et al., 2015, "Drug resistance in sea lice: a threat to salmonid aquaculture". Trends in Parasitology, Vol 31, No. 2). Resistance towards organophosphates has been linked to Phe362Tyr mutation in the AChE coding gene. For pyrethroids several factors are likely to be involved in resistance, cytochrome P450 is involved in the detoxification of pyrethroids, as well as biomarkers in the mitochondrial DNA (Bakke et al., 2018,"Deltamethrin resistance in the salmon louse.
Lepeophtheirus salmonis (Kroyer): Maternal inheritance and reduced apoptosis." Scientific Reports, Vol. 8, 8450). Using these genes, it was demonstrated that medicinal treatments drive genetic selection towards a more resistant salmon lice population within a very short time span if there is no influx of sensitive genotypes (Jensen et al., 2017, "A selection study on laboratory-designed population of salmon lice (Lepeophtherius salrnonis) using organophosphatc and pyrcthroid pesticides", PLOS one12(5)e0178086).
PCR based methods for detection of resistance genes have been published for azamethiphos (EP 3 033 433 A 1 ), pyrethroids (EP 3 030 673 Al, EP 3 030 674 Al) as well as the catalase gene for hydrogen peroxide resistance (EP 3 164 502 B1).
Hydrogen peroxide has been demonstrated to be the least harmful to non-target organisms, highly effective against certain stages of louse development and most environmentally responsible (Burridge, L. 2013, -A review of potential environmental risks associated with the use of pesticides to treat Atlantic salmon against infestations of sea lice in southwest New Brunswick, Canada, DFO Can. Sci. Advis. Sec. Res. Doc. 2013/050. iv + 25 p). Interox Paraniove 50 is a commercially available hydrogen peroxide product for the treatment of sea lice. It contains 50%
hydrogen peroxide.
Hydrogen peroxide is only efficacious on post-chalimus stages of sea lice; it must be used in conjunction with other pest management techniques to maximize treatment benefits. There are conflicting results regarding viability of sea lice post treatment as well as the ability of lice re-infection. Because there are no techniques currently developed to remove sea lice from a tarp treatment, timing of treatment to target post-chalimus stage lice is essential. Recent studies of egg viability and nauplii survival post-treatment do indicate that nauplii survival reaches 0 within days of hatch.
Hydrogen peroxide breaks down readily into water and is considered the anti-louse treatment with least environmental risk. Recent studies comparing the effects of Interox Paramove 50, Salmosan , and AlphaMax on American lobster, mysid shrimp and sand shrimp showed that
3 Interox Paramove 50 had the least impact on these non-target organisms.
Unlike other anti-louse chemotherapeutants. hydrogen peroxide does not have a withdrawal period.
Hydrogen peroxide is believed to be available for use in all major salmon farming countries. It was a common louse treatment in the 1990's but was subsequently replaced by in-feed louse treatments and other bath treatments until a recent resurgence. In 2009, the use of H202 in aquaculture in Norway was 308 tons, in 2010 it was 3071 tons and in 2012 it was 2538 tons, further it was 8262 tons in 2013, 31577 tons in 2014, 43 246 tons in 2015, 26597 tons in 2016 and 9277 tons in 2017 (cf. Norwegian Institute of Public Health 2018 www.fhi.no).
Organisms naturally produce hydrogen peroxide as a by-product of oxidative metabolism.
Consequently, nearly all living things (specifically, all obligate and facultative aerobes) possess enzymes known as catalase and peroxidases, which harmlessly and catalytically decompose low concentrations of hydrogen peroxide to water and oxygen. Two theories have been proposed to explain the therapeutic effects of hydrogen peroxide.
The first is that bactericidal action is through the formation of hydroxyl radicals and its effect on DNA
(Imlay J. A. (1987), "The mechanisms of toxicity of hydrogen peroxide", PhD
Thesis, University of California, Berkeley). The second, proposed to explain toxicity to protistans and monogeneans, is the liberation of molecular oxygen as a result of catalase action (Schaperclaus et al., eds. (1979), Fishkrankheiten, 4th edn. Academic-Verlag.
Berlin).
Resistance of insects to pesticides develops through genetic selection of individuals (Soderlund D.M. & Bloomquist J.R. (1990), -Molecular mechanisms of insecticide resistance. In: Pesticide Resistance in Arthropods" (ed. by R.T. Roush &
B.E.Tabashnik), pp. 58-96. Chapman & Hall, London) and, in lice, this may be selection for individuals with cuticle that provides a barrier to penetration by hydrogen peroxide or the presence of detoxifying enzymes such as catalase, glutathione reductase, glutathione synthetase, superoxide dismutase, and glucose-6-phosphate dehydrogenase. An alternative explanation could be prior induction as reported for Aeromonas scampi-Jidda pre-exposed to low concentrations of hydrogen peroxide (Barnes et al., (1999a) "Superoxide dismutase and catalase in Photobacterium damselae suhsp. piscicida and their roles in resistance to reactive oxygen species", Microbiology 145, 483-494 & Barnes et al. (1999b), "Peroxide-inducible catalase in Aeromonas salmonicida subsp. salmonicida protects against exogenous hydrogen peroxide and killing by activated rainbow trout, Oncorhynchus mykiss. L. macrophages-, Microbial Pathogenesis 26, 149-158). These bacteria had catalase activity 20-fold higher when subsequently exposed to higher concentrations than in un-induced cultures.
Catalase is a common enzyme found in nearly all living organisms exposed to oxygen. It catalyzes the decomposition of hydrogen peroxide to water and oxygen (Chelikani et al.,January 2004, "Diversity of structures and properties among catalases", Cell. Mol. Life Sci. 61(2): 192-208). It is a very important enzyme in protecting the cell from oxidative damage by reactive oxygen species (ROS). Likewise, catalase has one of the highest turnover numbers of all enzymes; one catalase molecule can convert millions of molecules
Unlike other anti-louse chemotherapeutants. hydrogen peroxide does not have a withdrawal period.
Hydrogen peroxide is believed to be available for use in all major salmon farming countries. It was a common louse treatment in the 1990's but was subsequently replaced by in-feed louse treatments and other bath treatments until a recent resurgence. In 2009, the use of H202 in aquaculture in Norway was 308 tons, in 2010 it was 3071 tons and in 2012 it was 2538 tons, further it was 8262 tons in 2013, 31577 tons in 2014, 43 246 tons in 2015, 26597 tons in 2016 and 9277 tons in 2017 (cf. Norwegian Institute of Public Health 2018 www.fhi.no).
Organisms naturally produce hydrogen peroxide as a by-product of oxidative metabolism.
Consequently, nearly all living things (specifically, all obligate and facultative aerobes) possess enzymes known as catalase and peroxidases, which harmlessly and catalytically decompose low concentrations of hydrogen peroxide to water and oxygen. Two theories have been proposed to explain the therapeutic effects of hydrogen peroxide.
The first is that bactericidal action is through the formation of hydroxyl radicals and its effect on DNA
(Imlay J. A. (1987), "The mechanisms of toxicity of hydrogen peroxide", PhD
Thesis, University of California, Berkeley). The second, proposed to explain toxicity to protistans and monogeneans, is the liberation of molecular oxygen as a result of catalase action (Schaperclaus et al., eds. (1979), Fishkrankheiten, 4th edn. Academic-Verlag.
Berlin).
Resistance of insects to pesticides develops through genetic selection of individuals (Soderlund D.M. & Bloomquist J.R. (1990), -Molecular mechanisms of insecticide resistance. In: Pesticide Resistance in Arthropods" (ed. by R.T. Roush &
B.E.Tabashnik), pp. 58-96. Chapman & Hall, London) and, in lice, this may be selection for individuals with cuticle that provides a barrier to penetration by hydrogen peroxide or the presence of detoxifying enzymes such as catalase, glutathione reductase, glutathione synthetase, superoxide dismutase, and glucose-6-phosphate dehydrogenase. An alternative explanation could be prior induction as reported for Aeromonas scampi-Jidda pre-exposed to low concentrations of hydrogen peroxide (Barnes et al., (1999a) "Superoxide dismutase and catalase in Photobacterium damselae suhsp. piscicida and their roles in resistance to reactive oxygen species", Microbiology 145, 483-494 & Barnes et al. (1999b), "Peroxide-inducible catalase in Aeromonas salmonicida subsp. salmonicida protects against exogenous hydrogen peroxide and killing by activated rainbow trout, Oncorhynchus mykiss. L. macrophages-, Microbial Pathogenesis 26, 149-158). These bacteria had catalase activity 20-fold higher when subsequently exposed to higher concentrations than in un-induced cultures.
Catalase is a common enzyme found in nearly all living organisms exposed to oxygen. It catalyzes the decomposition of hydrogen peroxide to water and oxygen (Chelikani et al.,January 2004, "Diversity of structures and properties among catalases", Cell. Mol. Life Sci. 61(2): 192-208). It is a very important enzyme in protecting the cell from oxidative damage by reactive oxygen species (ROS). Likewise, catalase has one of the highest turnover numbers of all enzymes; one catalase molecule can convert millions of molecules
4 of hydrogen peroxide to water and oxygen each second (Goodsell (2004-09-01), ''Catalase.
Molecule of the Month-, RCSB Protein Data Bank. Retrieved 2007-02-11).
The development of resistance by sea lice to medicines and its management is one of the main concerns in sea lice control, particularly when the range of medicines is limited.
Resistance of sea lice to pesticides, organophosphates, pyrethroids and H202 is well established. Reduced sensitivity towards hydrogen peroxide (H202) was first reported in Scotland (Treasurer et al. (2000), "Resistance of sea lice, Lepeophtheirus salmonis (Kroyer), to hydrogen peroxide on farmed Atlantic salmon, Salmo salar Aquaculture Research, 31, 855-860), and from Norway in 2013 (Helgesen et al., 2015, "First report of reduced sensitivity towards hydrogen peroxide found in the salmon louse Lepeophtheirus salmonis in Norway", Aquaculture Reports 1, 37-42). It has been documented that increased catalase activity plays a role in H202 resistance in salmon lice.
Increased catalase expression and subsequent enhanced catalase activity is a mechanism for H202 resistance in salmon lice, and molecular screening methods could be developed on this basis. (Helgesen et al.,2015 "First report of reduced sensitivity towards hydrogen peroxide found in the salmon louse Lepeophtheirus salmonis in Norway", Aquaculture Reports 1, 37-42). The sequence expressing the catalase gene and the methods for using this gene as a resistance marker for H202 resistance in sea lice is disclosed in European Patent application EP 3 164 502 Bl.
Data shows that the catalase gene is probably induced by the exposure of lice to H202. It has however been found that if I-1702 is not applied as sea lice treatment for a period of time, the catalase expressions could return to its normal expression values, similar to the sensitive louse levels (unpublished data). Thus, there is a need for improved methods for detection of H202 resistance in sea lice.
Efficient, sensitive, stable and reliable methods for diagnosing resistance are crucial in order to manage and control drug resistance. Early detection of reduced sensitivity to a chemical can enable effective countermeasures to be enforced at a time point when these have a greater probability of being effective. Therefore, accurate, stable and speedy identification of hydrogen peroxide (H202) resistant sea lice is crucial.
Detection of hydrogen peroxide resistance prior to treatment, and the use of such analyses after treatment to evaluate treatment efficacy constitutes an important determinant for the integrated pest management (IPM) in the aquaculture industry.
Summary of invention The present invention is based on the surprising finding that resistance towards hydrogen peroxide commonly used to combat sea lice infestation is linked to the expression of a set of genes that are either downregulated or upregulated in hydrogen peroxide resistant sea lice.
In particular, it has been found that the expression of a gene encoding an aquaglyceroporin (Glp1_v2) is downregulated in HA}, resistant adult female sea lice.
Also, the endoplasmic reticulum resident protein 29 (ERP29) is downregulated in 11202 resistant sea lice.
Furthermore, it has been found that the genes encoding a DNA polymerase (delta subunit
Molecule of the Month-, RCSB Protein Data Bank. Retrieved 2007-02-11).
The development of resistance by sea lice to medicines and its management is one of the main concerns in sea lice control, particularly when the range of medicines is limited.
Resistance of sea lice to pesticides, organophosphates, pyrethroids and H202 is well established. Reduced sensitivity towards hydrogen peroxide (H202) was first reported in Scotland (Treasurer et al. (2000), "Resistance of sea lice, Lepeophtheirus salmonis (Kroyer), to hydrogen peroxide on farmed Atlantic salmon, Salmo salar Aquaculture Research, 31, 855-860), and from Norway in 2013 (Helgesen et al., 2015, "First report of reduced sensitivity towards hydrogen peroxide found in the salmon louse Lepeophtheirus salmonis in Norway", Aquaculture Reports 1, 37-42). It has been documented that increased catalase activity plays a role in H202 resistance in salmon lice.
Increased catalase expression and subsequent enhanced catalase activity is a mechanism for H202 resistance in salmon lice, and molecular screening methods could be developed on this basis. (Helgesen et al.,2015 "First report of reduced sensitivity towards hydrogen peroxide found in the salmon louse Lepeophtheirus salmonis in Norway", Aquaculture Reports 1, 37-42). The sequence expressing the catalase gene and the methods for using this gene as a resistance marker for H202 resistance in sea lice is disclosed in European Patent application EP 3 164 502 Bl.
Data shows that the catalase gene is probably induced by the exposure of lice to H202. It has however been found that if I-1702 is not applied as sea lice treatment for a period of time, the catalase expressions could return to its normal expression values, similar to the sensitive louse levels (unpublished data). Thus, there is a need for improved methods for detection of H202 resistance in sea lice.
Efficient, sensitive, stable and reliable methods for diagnosing resistance are crucial in order to manage and control drug resistance. Early detection of reduced sensitivity to a chemical can enable effective countermeasures to be enforced at a time point when these have a greater probability of being effective. Therefore, accurate, stable and speedy identification of hydrogen peroxide (H202) resistant sea lice is crucial.
Detection of hydrogen peroxide resistance prior to treatment, and the use of such analyses after treatment to evaluate treatment efficacy constitutes an important determinant for the integrated pest management (IPM) in the aquaculture industry.
Summary of invention The present invention is based on the surprising finding that resistance towards hydrogen peroxide commonly used to combat sea lice infestation is linked to the expression of a set of genes that are either downregulated or upregulated in hydrogen peroxide resistant sea lice.
In particular, it has been found that the expression of a gene encoding an aquaglyceroporin (Glp1_v2) is downregulated in HA}, resistant adult female sea lice.
Also, the endoplasmic reticulum resident protein 29 (ERP29) is downregulated in 11202 resistant sea lice.
Furthermore, it has been found that the genes encoding a DNA polymerase (delta subunit
5 3) is upregulated in sea lice resistant to H202 It has furthermore been found that expression of the gene encoding Nesprin-like is upregulated in H202 resistant sea lice.
It has furthermore been found that a gene encoding a yet unknown protein (herein named NA, SEQ ID No. 10) is upregulated in 11202 resistant sea lice.
The sea lice that may be analysed according to the present invention is one or more copepods, e.g. belonging to the family Caligidae.
According to one embodiment, the copepod is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi.
According to one embodiment, the copepod is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei and Caligus elongates.
According to one embodiment, the copepod is Caligus rogercresseyi.
According to one embodiment the copepod is Lepeophtheirus salmonis.
According to a first aspect, a method is provided for the detection of hydrogen peroxide resistance in one or more adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more adult female sea lice from infested fish or water samples;
b) isolating genomic material from the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERY29), DNA polymer ase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one embodiment of the first aspect, said method is provided for the detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei and Caligus elongatus.
According to one embodiment of the first aspect, said method is provided for the detection of hydrogen peroxide resistance in one or more adult female sea lice wherein the sea lice is Lepeophtheirus salmonis.
It has furthermore been found that a gene encoding a yet unknown protein (herein named NA, SEQ ID No. 10) is upregulated in 11202 resistant sea lice.
The sea lice that may be analysed according to the present invention is one or more copepods, e.g. belonging to the family Caligidae.
According to one embodiment, the copepod is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi.
According to one embodiment, the copepod is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei and Caligus elongates.
According to one embodiment, the copepod is Caligus rogercresseyi.
According to one embodiment the copepod is Lepeophtheirus salmonis.
According to a first aspect, a method is provided for the detection of hydrogen peroxide resistance in one or more adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more adult female sea lice from infested fish or water samples;
b) isolating genomic material from the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERY29), DNA polymer ase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one embodiment of the first aspect, said method is provided for the detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei and Caligus elongatus.
According to one embodiment of the first aspect, said method is provided for the detection of hydrogen peroxide resistance in one or more adult female sea lice wherein the sea lice is Lepeophtheirus salmonis.
6 According to one embodiment of the first aspect, said method is provided for the detection of hydrogen peroxide resistance in one or more adult female sea lice wherein the sea lice is Caligus rogercresseyi.
According to one embodiment of the first aspect, said method is provided for determining the expression level of at least one of the genes encoding a protein having a sequence selected from the group consisting of:
SEQ ID No. 2 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 2;
SEQ ID No. 4 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 4;
SEQ ID No. 6 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 6;
SEQ ID No. 8 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 8;
SEQ ID No. 10 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 10.
According one embodiment of the first aspect, said method is provided for determining the expression level of at least one of the genes comprising a sequence selected from the group consisting of:
SEQ ID No. 1 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 1;
,SEQ ID No. 3 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 3;
SEQ ID No. 5 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 5;
SEQ ID No. 7 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 7;
SEQ ID No. 9 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 9.
According to one embodiment of the first aspect, said method is provided for determining the expression level of at least one of the genes encoding a protein having a sequence selected from the group consisting of:
SEQ ID No. 2 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 2;
SEQ ID No. 4 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 4;
SEQ ID No. 6 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 6;
SEQ ID No. 8 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 8;
SEQ ID No. 10 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 10.
According one embodiment of the first aspect, said method is provided for determining the expression level of at least one of the genes comprising a sequence selected from the group consisting of:
SEQ ID No. 1 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 1;
,SEQ ID No. 3 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 3;
SEQ ID No. 5 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 5;
SEQ ID No. 7 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 7;
SEQ ID No. 9 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 9.
7 According to one embodiment of the first aspect, the method according to the present invention involves determination of the expression levels of at least two of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glpl _v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 is determined.
According to one embodiment of the first aspect, the method according to the present invention involves determination the expression levels of a gene encoding catalase in addition to one or more of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10. Said catalase gene can be selected from the group consisting of SEQ Ill No. 11, SEQ
ID No. 12, SEQ ID No. 13, and SEQ ID No. 14 or variants or fragments thereof being at least 70 % identical with SEQ ID No. 11, SEQ ID No. 12, SEQ ID No. 13, and SEQ
ID No.
14, respectively.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding aquaglyceroporin (Glp1_v2) is downregulated compared with the expression level of aquaglyceroporin (Glpl v2) in one or more 11702 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding endoplasmic reticulum resident protein 29 (ERP29) is downregulated compared with the expression level of endoplasmic reticulum resident protein 29 (ERP29) in one or more 11202 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding DNA
polymerase (delta subunit 3) is upregulated compared with the expression level of DNA polymerase (delta subunit 3) in one or more H2O, sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding nesprin-like is upregulated compared with the expression level of nesprin-like in one or more sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H2O, resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding and the protein of SEQ
ID No. 10 is upregulated compared with the expression level of and the protein of SEQ ID
No. 10 in one or more H902 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more adult female sea lice according to the first aspect, wherein step (c) of the present invention comprise the steps of:
According to one embodiment of the first aspect, the method according to the present invention involves determination the expression levels of a gene encoding catalase in addition to one or more of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10. Said catalase gene can be selected from the group consisting of SEQ Ill No. 11, SEQ
ID No. 12, SEQ ID No. 13, and SEQ ID No. 14 or variants or fragments thereof being at least 70 % identical with SEQ ID No. 11, SEQ ID No. 12, SEQ ID No. 13, and SEQ
ID No.
14, respectively.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding aquaglyceroporin (Glp1_v2) is downregulated compared with the expression level of aquaglyceroporin (Glpl v2) in one or more 11702 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding endoplasmic reticulum resident protein 29 (ERP29) is downregulated compared with the expression level of endoplasmic reticulum resident protein 29 (ERP29) in one or more 11202 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding DNA
polymerase (delta subunit 3) is upregulated compared with the expression level of DNA polymerase (delta subunit 3) in one or more H2O, sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding nesprin-like is upregulated compared with the expression level of nesprin-like in one or more sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H2O, resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding and the protein of SEQ
ID No. 10 is upregulated compared with the expression level of and the protein of SEQ ID
No. 10 in one or more H902 sensitive sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H202 resistance in one or more adult female sea lice according to the first aspect, wherein step (c) of the present invention comprise the steps of:
8 (c1) providing one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence of SEQ ID No. 1, SEQ ID No. 3, SEQ TD
No. 5.
SEQ ID No. 7, SEQ ID No. 9 or a complementary oligonucicotide of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, SEQ ID No. 9, respectively; and (c2) determining the expression level of at least one of the genes selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, or variants or fragments thereof being at least 70 % identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ
Ill No. 9, respectively, by measuring the RNA expression level of said genes in the collected sea lice, wherein said sea lice is resistant to H202 if having reduced levels of expression of the genes encoding aquaglyceroporin (Glpl_v2) and/or endoplasmic reticulum resident protein 29 (ERP29), and/or elevated levels of RNA-expression of the genes encoding DNA polymerase (delta subunit 3), and/or nesprin-like and/or the protein of SEQ ID No. 10 compared with one or more non-resistant sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H702 resistance in one or more female adult sea lice according to the first aspect of the present invention, comprising the steps of (a) collecting one or more sea lice from infested fish or water samples;
(b) isolating DNA or RNA from the collected sea lice;
(c) providing a pair of PCR primers capable of hybridising under stringent conditions to at least one of the genes selected from the group consisting of SEQ ID No.
1, SEQ
ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively;
(d) performing PCR on the isolated DNA or RNA using the pair of PCR primers of (c);
(e) determining the expression level of one or more of said genes comparing the level of the expression of said genes in the collected sea lice with the level of control standard or a gene expression sample control.
The expression of the one or more genes in the collected sea lice or water sample is according to one aspect of the invention compared with the expression level of said genes in one or more non-resistant sea lice.
According to a second aspect, a method is provided for the detection of hydrogen peroxide resistance in one or more sea lice wherein the sea lice is of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ER P29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
No. 5.
SEQ ID No. 7, SEQ ID No. 9 or a complementary oligonucicotide of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, SEQ ID No. 9, respectively; and (c2) determining the expression level of at least one of the genes selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, or variants or fragments thereof being at least 70 % identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ
Ill No. 9, respectively, by measuring the RNA expression level of said genes in the collected sea lice, wherein said sea lice is resistant to H202 if having reduced levels of expression of the genes encoding aquaglyceroporin (Glpl_v2) and/or endoplasmic reticulum resident protein 29 (ERP29), and/or elevated levels of RNA-expression of the genes encoding DNA polymerase (delta subunit 3), and/or nesprin-like and/or the protein of SEQ ID No. 10 compared with one or more non-resistant sea lice.
According to one embodiment of the first aspect, the present invention provides a method for determination of H702 resistance in one or more female adult sea lice according to the first aspect of the present invention, comprising the steps of (a) collecting one or more sea lice from infested fish or water samples;
(b) isolating DNA or RNA from the collected sea lice;
(c) providing a pair of PCR primers capable of hybridising under stringent conditions to at least one of the genes selected from the group consisting of SEQ ID No.
1, SEQ
ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively;
(d) performing PCR on the isolated DNA or RNA using the pair of PCR primers of (c);
(e) determining the expression level of one or more of said genes comparing the level of the expression of said genes in the collected sea lice with the level of control standard or a gene expression sample control.
The expression of the one or more genes in the collected sea lice or water sample is according to one aspect of the invention compared with the expression level of said genes in one or more non-resistant sea lice.
According to a second aspect, a method is provided for the detection of hydrogen peroxide resistance in one or more sea lice wherein the sea lice is of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ER P29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
9 According to one embodiment of the second aspect, said method is provided for determining the expression level of at least one of the genes encoding a protein having a sequence selected from the group consisting of:
SEQ ID No. 4 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 4;
SEQ ID No. 6 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 6;
SEQ ID No. 8 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 8;
SEQ ID No. 10 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 10.
According one embodiment of the second aspect, said method is provided for determining the expression level of at least one of the genes comprising a sequence selected from the group consisting of:
SEQ ID No. 3 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 3;
SEQ ID No. 5 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 5;
SEQ ID No. 7 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 7;
SEQ ID No. 9 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 9.
According to one embodiment of the second aspect, the method according to the present invention involves determination of the expression levels of at least two of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 is determined.
According to one embodiment of the second aspect, the method according to the present invention involves determination the expression levels of a gene encoding catalase in addition to one or more of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. Said catalase gene can be selected from the group consisting of SEQ ID No. 11, SEQ ID No. 12, SEQ ID No.
13, and SEQ ID No. 14 or variants or fragments thereof being at least 70 % identical with SEQ ID
No. 11, SEQ ID No. 12, SEQ ID No. 13, and SEQ ID No. 14, respectively.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or 5 more sea lice is found to be resistant if the expression of the gene encoding endoplasmic reticulum resident protein 29 (ERP29) is downregulated compared with the expression level of endopl asmic reticulum resident protein 29 (ERP29) in one or more 1-1202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a
SEQ ID No. 4 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 4;
SEQ ID No. 6 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 6;
SEQ ID No. 8 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 8;
SEQ ID No. 10 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ Ill No. 10.
According one embodiment of the second aspect, said method is provided for determining the expression level of at least one of the genes comprising a sequence selected from the group consisting of:
SEQ ID No. 3 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 3;
SEQ ID No. 5 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 5;
SEQ ID No. 7 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 7;
SEQ ID No. 9 or variants or fragments thereof being at least 70 % identical, such as 80 %
identical, such as 85% identical, such as 90% identical, such as 92%
identical, such as 95%
identical, such as 98% identical, such as 99% identical with SEQ ID No. 9.
According to one embodiment of the second aspect, the method according to the present invention involves determination of the expression levels of at least two of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 is determined.
According to one embodiment of the second aspect, the method according to the present invention involves determination the expression levels of a gene encoding catalase in addition to one or more of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. Said catalase gene can be selected from the group consisting of SEQ ID No. 11, SEQ ID No. 12, SEQ ID No.
13, and SEQ ID No. 14 or variants or fragments thereof being at least 70 % identical with SEQ ID
No. 11, SEQ ID No. 12, SEQ ID No. 13, and SEQ ID No. 14, respectively.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or 5 more sea lice is found to be resistant if the expression of the gene encoding endoplasmic reticulum resident protein 29 (ERP29) is downregulated compared with the expression level of endopl asmic reticulum resident protein 29 (ERP29) in one or more 1-1202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a
10 method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding DNA
polymerase (delta subunit 3) is upregulated compared with the expression level of DNA
polymerase (delta subunit 3) in one or more H202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding nesprin-like is upregulated compared with the expression level of nesprin-like in one or more sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding and the protein of SEQ ID No. 10 is upregulated compared with the expression level of and the protein of SEQ ID No. 10 in one or more H202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein step (c) of the fourth aspect of the present invention comprise the steps of:
(el) providing one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence of SEQ ID No. 3, SEQ ID No. 5. SEQ ID
No. 7, SEQ ID No. 9 or a complementary oligonucleotide of SEQ ID No. 3, SEQ ID No. 5.
SEQ ID No. 7, SEQ ID No. 9, respectively; and (c2) determining the expression level of at least one of the genes selected from the group consisting of SEQ Ill No. 3, SEQ Ill No. 5. SEQ ID No. 7, and SEQ Ill No. 9, or variants or fragments thereof being at least 70 % identical with the entire length of SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively, by measuring the RNA expression level of said genes in the collected sea lice, wherein said sea lice is resistant to H202 if having reduced levels of expression of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), and/or elevated levels of RNA-expression of the genes encoding DNA polymerase (delta subunit 3), and/or nesprin-like and/or the protein of SEQ ID No. 10 compared with one or more non-resistant sea lice.
polymerase (delta subunit 3) is upregulated compared with the expression level of DNA
polymerase (delta subunit 3) in one or more H202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding nesprin-like is upregulated compared with the expression level of nesprin-like in one or more sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein the one or more sea lice is found to be resistant if the expression of the gene encoding and the protein of SEQ ID No. 10 is upregulated compared with the expression level of and the protein of SEQ ID No. 10 in one or more H202 sensitive sea lice.
According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice, wherein step (c) of the fourth aspect of the present invention comprise the steps of:
(el) providing one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence of SEQ ID No. 3, SEQ ID No. 5. SEQ ID
No. 7, SEQ ID No. 9 or a complementary oligonucleotide of SEQ ID No. 3, SEQ ID No. 5.
SEQ ID No. 7, SEQ ID No. 9, respectively; and (c2) determining the expression level of at least one of the genes selected from the group consisting of SEQ Ill No. 3, SEQ Ill No. 5. SEQ ID No. 7, and SEQ Ill No. 9, or variants or fragments thereof being at least 70 % identical with the entire length of SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively, by measuring the RNA expression level of said genes in the collected sea lice, wherein said sea lice is resistant to H202 if having reduced levels of expression of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), and/or elevated levels of RNA-expression of the genes encoding DNA polymerase (delta subunit 3), and/or nesprin-like and/or the protein of SEQ ID No. 10 compared with one or more non-resistant sea lice.
11 According to one embodiment of the second aspect, the present invention provides a method for determination of H202 resistance in one or more sea lice according to the second aspect of the present invention, comprising the steps of (a) collecting one or more sea lice from infested fish or water samples;
(b) isolating DNA or RNA from the collected sea lice;
(c) providing a pair of PCR primers capable of hybridizing under stringent conditions to at least one of the genes selected from the group consisting of SEQ ID No.
3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively;
(d) performing PCR on the isolated DNA or RNA using the pair of PCR primers of (c);
(e) determining the expression level of one or more of said genes comparing the level of the expression of said genes in the collected sea lice with the level of control standard or a gene expression sample control.
The expression of the one or more genes in the collected sea lice or water sample is according to one aspect of the invention compared with the expression level of said genes in one or more non-resistant sea lice.
In a third aspect the present invention furthermore provides the usc of one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ Ill No. 1, SEQ Ill No. 3, SEQ Ill No. 5. SEQ Ill No. 7, and SEQ
Ill No. 9, or a complementary oligonucleotide of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5. SEQ
ID No. 7, and SEQ ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice according to the method of the first aspect.
In one embodiment according to the third aspect, the one or more isolated oligonucleotide sequence is used for determination of hydrogen peroxide resistance in adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to a fourth aspect the present invention furthermore provides the use of one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, or a complementary oligonucleotide of SEQ Ill No. 3, SEQ Ill No. 5. SEQ Ill No. 7, and SEQ
ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice according to the second aspect wherein the sea lice is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi, According to yet another aspect, one or more mentioned isolated oligonucleotide sequence according to the third or fourth aspect may be used together with isolated oligonucleotide sequence for determining catalase expression wherein the isolated oligonucleotide sequence used in determining hydroxy peroxide resistance according to the present use is selected from the group consisting of SEQ ID No. 18, SEQ ID No. 19, SEQ ID NO.
20 and SEQ ID No. 21.
(b) isolating DNA or RNA from the collected sea lice;
(c) providing a pair of PCR primers capable of hybridizing under stringent conditions to at least one of the genes selected from the group consisting of SEQ ID No.
3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively;
(d) performing PCR on the isolated DNA or RNA using the pair of PCR primers of (c);
(e) determining the expression level of one or more of said genes comparing the level of the expression of said genes in the collected sea lice with the level of control standard or a gene expression sample control.
The expression of the one or more genes in the collected sea lice or water sample is according to one aspect of the invention compared with the expression level of said genes in one or more non-resistant sea lice.
In a third aspect the present invention furthermore provides the usc of one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ Ill No. 1, SEQ Ill No. 3, SEQ Ill No. 5. SEQ Ill No. 7, and SEQ
Ill No. 9, or a complementary oligonucleotide of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5. SEQ
ID No. 7, and SEQ ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice according to the method of the first aspect.
In one embodiment according to the third aspect, the one or more isolated oligonucleotide sequence is used for determination of hydrogen peroxide resistance in adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to a fourth aspect the present invention furthermore provides the use of one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, or a complementary oligonucleotide of SEQ Ill No. 3, SEQ Ill No. 5. SEQ Ill No. 7, and SEQ
ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice according to the second aspect wherein the sea lice is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi, According to yet another aspect, one or more mentioned isolated oligonucleotide sequence according to the third or fourth aspect may be used together with isolated oligonucleotide sequence for determining catalase expression wherein the isolated oligonucleotide sequence used in determining hydroxy peroxide resistance according to the present use is selected from the group consisting of SEQ ID No. 18, SEQ ID No. 19, SEQ ID NO.
20 and SEQ ID No. 21.
12 The present invention furthermore provides according to yet another aspect a kit for detection of hydrogen peroxide resistance in sea lice comprising one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, or a complementary oligonucleotide of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ
ID
No. 7, and SEQ ID No. 9, respectively, and wherein the one or more isolated oligonucleotide sequence is not SEQ ID No. 23.
The present invention provides according to yet a further aspect a DNA
molecule encoding a protein comprising an amino acid sequence selected from the group consisting of SEQ ID
No. 4, SEQ ID No. 6. SEQ ID No. 8, and SEQ ID No. 10.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 1 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3 or variants thereof being at least 80% identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 3, SEQ ID No. 5 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID
No. 5 SEQ ID No. 7 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID
No. 5.
SEQ ID No. 7, and SEQ ID No. 9, or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 9.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5. SEQ ID
No. 7, and SEQ Ill No. 9.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 3, SEQ ID No. 5. SEQ ID No.
7, and SEQ ID No. 9.
The present invention and its various embodiments will be described in more detail in the following.
ID
No. 7, and SEQ ID No. 9, respectively, and wherein the one or more isolated oligonucleotide sequence is not SEQ ID No. 23.
The present invention provides according to yet a further aspect a DNA
molecule encoding a protein comprising an amino acid sequence selected from the group consisting of SEQ ID
No. 4, SEQ ID No. 6. SEQ ID No. 8, and SEQ ID No. 10.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 1 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3 or variants thereof being at least 80% identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 3, SEQ ID No. 5 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID
No. 5 SEQ ID No. 7 or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 1, SEQ ID No. 3, SEQ ID
No. 5.
SEQ ID No. 7, and SEQ ID No. 9, or variants thereof being at least 80 % identical, such as 85%
identical, such as 90% identical, such as 92% identical, such as 95% identical, such as 98%
identical, such as 99% identical with the entire length of SEQ ID No. 9.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5. SEQ ID
No. 7, and SEQ Ill No. 9.
According to yet another aspect, a DNA molecule is provided comprising a sequence selected from the group consisting of SEQ ID No. 3, SEQ ID No. 5. SEQ ID No.
7, and SEQ ID No. 9.
The present invention and its various embodiments will be described in more detail in the following.
13 Figures Figure 1 show gene expression data (normalized counts) of catalase and the five genes significantly differentially expressed in the 2013, PO and F2-H202 groups (DNA-polymerase delta subunit 3, Nesprin-like, NA, ERP29 and G1p1_v2): Ls A-2013 (white circles), Ls V-2013 (grey circles), Ls A-PO (white triangles), Ls V-PO (grey triangles), Ls F2- H202-S (sensitive lice, white diamonds), Ls F2- H202-R (resistant lice, grey diamonds).
Solid lines represent the mean in each group. Dark grey and black diamonds in the Ls F241 H202-R group represent the same individual lice in both catalase and Glp1_v2 graphs.
Figure 2 illustrates the number of genes differentially expressed in the H202 resistant lice (2013, PO and F2- H202 groups), separately for up- and down-regulated genes.
Numbers in the circles represent the unique genes differentially expressed in each group.
Numbers in the intersection of the circles represent the differentially expressed genes shared between two or three groups.
Figure 3. qPCR validation for catalase and Glp1_v2 genes in the RNAseq louse groups: Ls A-2013 (white circles), Ls V-2013 (grey circles), Ls A-PO (white triangles) and Ls V-PO
(grey triangles) lice. Solid lines represent the mean in each group. Data shown as fold change (log2A-(AACt)) referred to Ls A 2013 and Ls A PO lice (calibrator sample). Letters above the data points (a,b and c) represent the statistically significant differences between the louse groups, groups sharing the same letter are not statistically different (a = 0.05).
Detailed description of the invention The present invention provides an in vitro method and means for determination of hydrogen peroxide resistance in crustaceans, in particular hydroxy peroxide resistance in sea lice. The method is based on the findings that determination of the expression levels of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 with an unknown function can be used to reveal whether sea lice is sensitive towards hydroxy peroxide treatment or not.
The present invention thus provides method for the detection of hydrogen peroxide resistance in one or more adult female sea lice selected from the group consisting of Lepeophtheirus sari-fortis, Caligus clernensei, Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from adult female of the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Optionally, in addition to the determination of the at least one mentioned genes of step (c), said method may also involve the determination of the expression level of the gene encoding catalase.
Solid lines represent the mean in each group. Dark grey and black diamonds in the Ls F241 H202-R group represent the same individual lice in both catalase and Glp1_v2 graphs.
Figure 2 illustrates the number of genes differentially expressed in the H202 resistant lice (2013, PO and F2- H202 groups), separately for up- and down-regulated genes.
Numbers in the circles represent the unique genes differentially expressed in each group.
Numbers in the intersection of the circles represent the differentially expressed genes shared between two or three groups.
Figure 3. qPCR validation for catalase and Glp1_v2 genes in the RNAseq louse groups: Ls A-2013 (white circles), Ls V-2013 (grey circles), Ls A-PO (white triangles) and Ls V-PO
(grey triangles) lice. Solid lines represent the mean in each group. Data shown as fold change (log2A-(AACt)) referred to Ls A 2013 and Ls A PO lice (calibrator sample). Letters above the data points (a,b and c) represent the statistically significant differences between the louse groups, groups sharing the same letter are not statistically different (a = 0.05).
Detailed description of the invention The present invention provides an in vitro method and means for determination of hydrogen peroxide resistance in crustaceans, in particular hydroxy peroxide resistance in sea lice. The method is based on the findings that determination of the expression levels of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 with an unknown function can be used to reveal whether sea lice is sensitive towards hydroxy peroxide treatment or not.
The present invention thus provides method for the detection of hydrogen peroxide resistance in one or more adult female sea lice selected from the group consisting of Lepeophtheirus sari-fortis, Caligus clernensei, Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from adult female of the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Optionally, in addition to the determination of the at least one mentioned genes of step (c), said method may also involve the determination of the expression level of the gene encoding catalase.
14 According to one aspect, the sea lice to be analysed is one or more adult female sea lice.
According to one aspect adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
In particular, it has been found that in hydroxy peroxide resistant adult female sea lice the expression of the gene encoding aquaglyceroporin (Glp1_v2) is significantly downregulated compared with the expression levels of said genes in sea lice being sensitive to hydroxy peroxide.
The present invention further provides method for the detection of hydrogen peroxide resistance in one or more sea lice wherein the sea lice is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Optionally, in addition to the determination of the at least one mentioned genes of step (c), said method may also involve the determination of the expression level of the gene encoding catalase.
Further, it has been found that in hydroxy peroxide resistant, the expression of the gene encoding cndoplasmic rcticulum resident protein 29 (ERP29)is significantly downregulated compared with the expression levels of said genes in sea lice being sensitive to hydroxy peroxide.
Furthermore, it has been found that expression of genes encoding DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, respectively, in resistant sea lice is significantly upregulated compared with the expression level of said genes in hydroxy peroxide sensitive sea lice.
Glp1_v2 is one of the aquaglyceroporins identified by Stavang et al. (2015) in L. salmonis (Stavang et al, 2015, Phylogenomic and functional analyses of salmon lice aquaporins uncover the molecular diversity of the superfamily in Arthropoda. BMC Genomics 16:618.
Stavang et al. (2015) identified a total of seven aquaporins in the salmon louse: two classical aquaporins (Bib and Prip-like or "PripL"), three aquaglyccroporins (Glp1_v1, Glp1_v2, Glp2, Glp3_v1 and G1p3_v2) and two unorthodox aquaporins (Aqp12-like 1 or "Aqp12L1" and Aqp12-like 2 or "Aqp12L2").
Aquaporins are protein channels that facilitate transport of water, other small solutes such as H202 and gasses (Bienert et al., 2007, Specific Aquaporins Facilitate the Diffusion of Hydrogen Peroxide across Membranes. The Journal of biological chemistry. 282.
1183-92;
Herrera and Garvin, 2011, Aquaporins as gas channels. Pflugers Arch - Eur J
Physiol 462:
623 ¨ 630; Miller et al., 2010, Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signalling, Proceedings of the National Academy of Sciences, 107 (36) 15681-15686; Stavang et al., 2015, supra; Thiagarajah et al., 2017, Aquaporin-3-mediated colonic epithelial responses, Proceedings of the National Academy of Sciences, 114 (3) 568-573; Zwiazek et al., 2017, Significance of oxygen transport through aquaporins, Scientific Reports, 7:40411).
5 Stavang et al. (2015), supra, identified a total of seven aquaporins in the salmon louse: two classical aquaporins (Bib and Prip-like or -PripL"), three aquaglyceroporins (Glpl vl, Glpl _v2, Glp2, Glp3_v1 and Glp3_v2) and two unorthodox aquaporins (Aqpl 2-likel or "Aqp12L1" and Aqp12-like 2 or "Aqp12L2"). Glp3 v2 was found to be expressed mostly in Nauplius II stage.
10 It has been demonstrated that certain aquaglyceroporins and unorthodox aquaporins are able to transport H202 through cell membranes in several organisms (Miller et al., 2010, supra; Thiagarajah et al., 2017, supra). Glps have an open pore configuration in L.
salmonis (Stavang et al., 2015, supra), also allowing bigger molecules than water, like urea and glycerol, to pass through the channel. Miller et al. (2010), supra, found that one
According to one aspect adult female sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
In particular, it has been found that in hydroxy peroxide resistant adult female sea lice the expression of the gene encoding aquaglyceroporin (Glp1_v2) is significantly downregulated compared with the expression levels of said genes in sea lice being sensitive to hydroxy peroxide.
The present invention further provides method for the detection of hydrogen peroxide resistance in one or more sea lice wherein the sea lice is selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Optionally, in addition to the determination of the at least one mentioned genes of step (c), said method may also involve the determination of the expression level of the gene encoding catalase.
Further, it has been found that in hydroxy peroxide resistant, the expression of the gene encoding cndoplasmic rcticulum resident protein 29 (ERP29)is significantly downregulated compared with the expression levels of said genes in sea lice being sensitive to hydroxy peroxide.
Furthermore, it has been found that expression of genes encoding DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, respectively, in resistant sea lice is significantly upregulated compared with the expression level of said genes in hydroxy peroxide sensitive sea lice.
Glp1_v2 is one of the aquaglyceroporins identified by Stavang et al. (2015) in L. salmonis (Stavang et al, 2015, Phylogenomic and functional analyses of salmon lice aquaporins uncover the molecular diversity of the superfamily in Arthropoda. BMC Genomics 16:618.
Stavang et al. (2015) identified a total of seven aquaporins in the salmon louse: two classical aquaporins (Bib and Prip-like or "PripL"), three aquaglyccroporins (Glp1_v1, Glp1_v2, Glp2, Glp3_v1 and G1p3_v2) and two unorthodox aquaporins (Aqp12-like 1 or "Aqp12L1" and Aqp12-like 2 or "Aqp12L2").
Aquaporins are protein channels that facilitate transport of water, other small solutes such as H202 and gasses (Bienert et al., 2007, Specific Aquaporins Facilitate the Diffusion of Hydrogen Peroxide across Membranes. The Journal of biological chemistry. 282.
1183-92;
Herrera and Garvin, 2011, Aquaporins as gas channels. Pflugers Arch - Eur J
Physiol 462:
623 ¨ 630; Miller et al., 2010, Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signalling, Proceedings of the National Academy of Sciences, 107 (36) 15681-15686; Stavang et al., 2015, supra; Thiagarajah et al., 2017, Aquaporin-3-mediated colonic epithelial responses, Proceedings of the National Academy of Sciences, 114 (3) 568-573; Zwiazek et al., 2017, Significance of oxygen transport through aquaporins, Scientific Reports, 7:40411).
5 Stavang et al. (2015), supra, identified a total of seven aquaporins in the salmon louse: two classical aquaporins (Bib and Prip-like or -PripL"), three aquaglyceroporins (Glpl vl, Glpl _v2, Glp2, Glp3_v1 and Glp3_v2) and two unorthodox aquaporins (Aqpl 2-likel or "Aqp12L1" and Aqp12-like 2 or "Aqp12L2"). Glp3 v2 was found to be expressed mostly in Nauplius II stage.
10 It has been demonstrated that certain aquaglyceroporins and unorthodox aquaporins are able to transport H202 through cell membranes in several organisms (Miller et al., 2010, supra; Thiagarajah et al., 2017, supra). Glps have an open pore configuration in L.
salmonis (Stavang et al., 2015, supra), also allowing bigger molecules than water, like urea and glycerol, to pass through the channel. Miller et al. (2010), supra, found that one
15 aquaglyceroporin (AQP3) and one unorthodox aquaporin (AQP8) transported 11202 through mammalian cell membranes. However, the classical aquaporin AQP1, did not transport H202.
Several authors have reported the role of aquaporins as drug transporters in other parasites, and the link between aquaporins and drug resistance (reviewed in Song et al., 2014, Parasite aquaporins: Current developments in drug facilitation and resistance, Biochimica et biophysica acta. 1840: 1566-1573). In Faghiri and Skelly (2009), The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake, FASEB J. 23(8): 2780-2789, it was shown that the presence of a putative aquaglyceroporin (SmAQP) in the tegument of the parasitic worm Schistosoma mansoni. It was proven that SmAQP can transport water and an anti-parasitic compound (potassium antimonyl tartrate) across the parasite tegument. In addition, parasites with reduced levels of SmAQP exhibited a greater resistance to the anti-parasitic agent. In Trypanosomatid parasites, like Leishmania or Trypanosoma spp., certain aquaporins transport trivalent metalloids (SbIII and AsIII) through the parasite membranes (reviewed in Mandal et al., 2014, Trypanosomatid Aquaporins: Roles in Physiology and Drug Response.
Diseases).
The aquaglyceroporin LmAQP1 transports SbIII in Leishmania spp (Gourbal et al., 2004, Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin.
The Journal of biological chemistry. 279. 31010-7). Drug resistant parasites showed down-regulation of LmAQP1 (Marquis et al., 2005, Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania, Mol Microbiol. Sep;57(6):1690-9), and the RNA levels correlated with the drug concentration. Resistance to melarsoprol and pentamidine is common among African trypanosomes (Baker et al., 2012, Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes, Proceedings of the National Academy of Sciences of the United States of America, 109(27), 10996-11001).
The authors found that the loss of function of an aquaglyceroporin, AQP2, was linked to drug resistance. Interestingly, a mitogen activated protein kinase 2 (MPK2) stabilizes LmAQP1 protein by phosphorylation in Leishmania major (Mandal et al., 2012), and dephosphorylation made LmAQP1 more susceptible to degradation. Altered AQP1 and
Several authors have reported the role of aquaporins as drug transporters in other parasites, and the link between aquaporins and drug resistance (reviewed in Song et al., 2014, Parasite aquaporins: Current developments in drug facilitation and resistance, Biochimica et biophysica acta. 1840: 1566-1573). In Faghiri and Skelly (2009), The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake, FASEB J. 23(8): 2780-2789, it was shown that the presence of a putative aquaglyceroporin (SmAQP) in the tegument of the parasitic worm Schistosoma mansoni. It was proven that SmAQP can transport water and an anti-parasitic compound (potassium antimonyl tartrate) across the parasite tegument. In addition, parasites with reduced levels of SmAQP exhibited a greater resistance to the anti-parasitic agent. In Trypanosomatid parasites, like Leishmania or Trypanosoma spp., certain aquaporins transport trivalent metalloids (SbIII and AsIII) through the parasite membranes (reviewed in Mandal et al., 2014, Trypanosomatid Aquaporins: Roles in Physiology and Drug Response.
Diseases).
The aquaglyceroporin LmAQP1 transports SbIII in Leishmania spp (Gourbal et al., 2004, Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin.
The Journal of biological chemistry. 279. 31010-7). Drug resistant parasites showed down-regulation of LmAQP1 (Marquis et al., 2005, Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania, Mol Microbiol. Sep;57(6):1690-9), and the RNA levels correlated with the drug concentration. Resistance to melarsoprol and pentamidine is common among African trypanosomes (Baker et al., 2012, Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes, Proceedings of the National Academy of Sciences of the United States of America, 109(27), 10996-11001).
The authors found that the loss of function of an aquaglyceroporin, AQP2, was linked to drug resistance. Interestingly, a mitogen activated protein kinase 2 (MPK2) stabilizes LmAQP1 protein by phosphorylation in Leishmania major (Mandal et al., 2012), and dephosphorylation made LmAQP1 more susceptible to degradation. Altered AQP1 and
16 MPK2 (by site-directed mutagenesis) reduced the drug uptake and drug sensitivity.
Catalase activity can also be regulated by reversible phosphorylation via kinase enzymes by increasing the affinity of the enzyme for H202 (Dawson and Storey, 2016, The reversible phosphorylation of catalase from the freeze-tolerant North American wood frog, Rana sylvatica, Biochim Biophys Acta. 1860(3):476-85). These studies suggest that drug sensitivity can be linked to regulation of gene expression, but also to post-translational modifications of proteins. In our L. salmonis RNAseq data (cf. examples below), we found four putative mitogen activated protein kinases differentially expressed in 14202 sensitive and resistant lice (data not shown).
Based on the finding of the inventors, determination of the expression level of one of the genes mentioned above each in particular is suitable to indicate whether one or more sea lice are resistant or sensitive towards hydrogen peroxide resistance. However, without being limited by theory, and based on the inventors findings regarding determination of hydroxy peroxide resistance based on catalase gene expression level in sea lice, it is according to one aspect provided a method for the detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei. Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least two of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (G1p1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, According to one aspect the sea lice is Caligus rogercresseyi According to yet another aspect, the above method may optionally also involve the determination of the expression level of catalase in the analysed one or more sea lice.
According to another aspect, step (c) involves determining the expression level of at least three, such as at least four of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glpl_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10. According to yet another aspect, step (c) involved determining the expression level of the genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10.
According to yet another aspect, the method of the invention involves the determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2) and endoplasmic reticulum resident protein 29 (ERP29), and optionally also determination of the expression level of a gene encoding catalase.
Catalase activity can also be regulated by reversible phosphorylation via kinase enzymes by increasing the affinity of the enzyme for H202 (Dawson and Storey, 2016, The reversible phosphorylation of catalase from the freeze-tolerant North American wood frog, Rana sylvatica, Biochim Biophys Acta. 1860(3):476-85). These studies suggest that drug sensitivity can be linked to regulation of gene expression, but also to post-translational modifications of proteins. In our L. salmonis RNAseq data (cf. examples below), we found four putative mitogen activated protein kinases differentially expressed in 14202 sensitive and resistant lice (data not shown).
Based on the finding of the inventors, determination of the expression level of one of the genes mentioned above each in particular is suitable to indicate whether one or more sea lice are resistant or sensitive towards hydrogen peroxide resistance. However, without being limited by theory, and based on the inventors findings regarding determination of hydroxy peroxide resistance based on catalase gene expression level in sea lice, it is according to one aspect provided a method for the detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei. Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least two of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (G1p1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, According to one aspect the sea lice is Caligus rogercresseyi According to yet another aspect, the above method may optionally also involve the determination of the expression level of catalase in the analysed one or more sea lice.
According to another aspect, step (c) involves determining the expression level of at least three, such as at least four of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glpl_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10. According to yet another aspect, step (c) involved determining the expression level of the genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10.
According to yet another aspect, the method of the invention involves the determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2) and endoplasmic reticulum resident protein 29 (ERP29), and optionally also determination of the expression level of a gene encoding catalase.
17 According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (GlpI v2) and DNA
polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2) and nesprin-like. and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of aquaglyceroporin (GlpI_v2) and the protein of SEQ ID No.
10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and DNA polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3) and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3) and the protein of SEQ Ill No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to another aspect, the method of the invention involves determination of the expression level of the genes encoding nesprin-like and the protein of SEQ ID
No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, a method is provided for detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Catigus rogercresseyi comprising the steps of a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least three of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2),
polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2) and nesprin-like. and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of aquaglyceroporin (GlpI_v2) and the protein of SEQ ID No.
10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and DNA polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29) and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3) and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3) and the protein of SEQ Ill No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to another aspect, the method of the invention involves determination of the expression level of the genes encoding nesprin-like and the protein of SEQ ID
No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, a method is provided for detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Catigus rogercresseyi comprising the steps of a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least three of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2),
18 endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogercresseyi According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl_v2), en doplasmi c reticulum resident protein 29 (ERP29), and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), nesprin-like, and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalasc.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29),
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogercresseyi According to yet another aspect, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl_v2), en doplasmi c reticulum resident protein 29 (ERP29), and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), nesprin-like, and the protein of SEQ ID No. 10, and optionally also determination of the expression level of a gene encoding catalasc.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and nesprin-like, and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29),
19 nesprin-like, and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to yet another, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, a method is provided for detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus elemensei, Caligus elongatus, and Caligus rogereresseyi comprising the steps of a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least four of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus sahnonis, Caligus elemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogereresseyi According to one embodiment, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Cilp l_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and nesprin-like; and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment , the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and the protein of SEQ ID
No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment , the method of the invention involves determination of the expression level of the genes cncoding aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), nesprin-like and the protein of SEQ ID No. 10;
and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According toone embodiment , the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No.
10; and optionally also determination of the expression level of a gene encoding catalase.
According toone embodiment , the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum 5 resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ Ill No. 10; and optionally also determination of the expression level of a gene encoding catalase.
Based on the teaching herein, i.e. that the expression level of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum 10 resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 are linked with hydrogen peroxide resistance in sea lice, the skilled person will acknowledge that various well known methods are available for the determination of the expression level of genes, and to determine whether the expression of a certain gene are downregulated or upregulated.
15 When referring to that the expression of a gen is "upregulated" it is to be understood to mean that the expression of the gene in question is increased compared with the expression level of said gene in a sea louse being sensitive towards hydrogen peroxide.
When referring to that the expression of a gen is "downregulated" it is to be understood to mean that the expression of the gene in question is decreased compared with the expression
According to yet another, the method of the invention involves determination of the expression level of the genes encoding DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to yet another aspect, a method is provided for detection of hydrogen peroxide resistance in one or more sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus elemensei, Caligus elongatus, and Caligus rogereresseyi comprising the steps of a) collecting one or more sea lice from infested fish or water samples;
b) isolating genomic material from any life stage of the collected sea lice;
and c) determining the expression level of at least four of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to one aspect the sea lice is an adult female sea lice.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus sahnonis, Caligus elemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogereresseyi According to one embodiment, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Cilp l_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and nesprin-like; and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment , the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glpl v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), and the protein of SEQ ID
No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment , the method of the invention involves determination of the expression level of the genes cncoding aquaglyceroporin (Glp l_v2), endoplasmic reticulum resident protein 29 (ERP29), nesprin-like and the protein of SEQ ID No. 10;
and optionally also determination of the expression level of a gene encoding catalase.
According to one embodiment, the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10; and optionally also determination of the expression level of a gene encoding catalase.
According toone embodiment , the method of the invention involves determination of the expression level of the genes encoding endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No.
10; and optionally also determination of the expression level of a gene encoding catalase.
According toone embodiment , the method of the invention involves determination of the expression level of the genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum 5 resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ Ill No. 10; and optionally also determination of the expression level of a gene encoding catalase.
Based on the teaching herein, i.e. that the expression level of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum 10 resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10 are linked with hydrogen peroxide resistance in sea lice, the skilled person will acknowledge that various well known methods are available for the determination of the expression level of genes, and to determine whether the expression of a certain gene are downregulated or upregulated.
15 When referring to that the expression of a gen is "upregulated" it is to be understood to mean that the expression of the gene in question is increased compared with the expression level of said gene in a sea louse being sensitive towards hydrogen peroxide.
When referring to that the expression of a gen is "downregulated" it is to be understood to mean that the expression of the gene in question is decreased compared with the expression
20 level of said gene in a sea louse being sensitive towards hydrogen peroxide.
The expression level may be measured by quantifying the levels of the gene product in question and may thus be determined by e.g. quantifying the amount of protein or quantifying the amount of mRNA.
The skilled person is aware of a number of methods that may be used to determine the mRNA level of an organism, such as a sea louse. For example, the skilled person would know the major methods of quantitatively detect mRNA levels including electrophoretic methods (e.g. Nothern bloting), DNA microarray-based methods and quantitative PCT
(Real-time PCR). Various protocols for determining expression levels are available, cf. e.g.
the step by step guide to Northern blot analysis by ThermoFisher Scientific (https://www.thermofisher.com/no/en/home/life-science/dna-rna-purification-analysis/nucleic-acid-gel-electrophoresis/northern-blotting.html). Other available analysis is the QuantiGene RNA Assay for gene expression profiling of Invitrogen0 provided ThermoFisher Scientifc (https://www.thermofisher.com/no/en/home/life-science/gene-expression-analysis-genotyping/quantigene-rna-assays.html).
Real-time PCR based methods (also called quantitative PCR or qPCR) allows monitoring DNA amplification during the PCR run in real time via fluorescent dyes that yield increasing fluorescent signal in direct proportion to the number of PCT
product molecules (amplicons) that are generated. Real time PCT methods is an efficient and by many considered as the preferred method for detection and quantification of DNA or RNA. An overview of the Real Time PCR technology is found in Methods in Molecular Biology, "Quantitative Real-Time PCR, Methods and Protocols, edited by Roberto Bias soni and Alessandro Raso, Springer Science+13usiness Media, New York, 2014 (https://www.gene-quantification.de/biassoni-raso-quantitative-real-time-per-ebook-2014.pdf).
The expression level may be measured by quantifying the levels of the gene product in question and may thus be determined by e.g. quantifying the amount of protein or quantifying the amount of mRNA.
The skilled person is aware of a number of methods that may be used to determine the mRNA level of an organism, such as a sea louse. For example, the skilled person would know the major methods of quantitatively detect mRNA levels including electrophoretic methods (e.g. Nothern bloting), DNA microarray-based methods and quantitative PCT
(Real-time PCR). Various protocols for determining expression levels are available, cf. e.g.
the step by step guide to Northern blot analysis by ThermoFisher Scientific (https://www.thermofisher.com/no/en/home/life-science/dna-rna-purification-analysis/nucleic-acid-gel-electrophoresis/northern-blotting.html). Other available analysis is the QuantiGene RNA Assay for gene expression profiling of Invitrogen0 provided ThermoFisher Scientifc (https://www.thermofisher.com/no/en/home/life-science/gene-expression-analysis-genotyping/quantigene-rna-assays.html).
Real-time PCR based methods (also called quantitative PCR or qPCR) allows monitoring DNA amplification during the PCR run in real time via fluorescent dyes that yield increasing fluorescent signal in direct proportion to the number of PCT
product molecules (amplicons) that are generated. Real time PCT methods is an efficient and by many considered as the preferred method for detection and quantification of DNA or RNA. An overview of the Real Time PCR technology is found in Methods in Molecular Biology, "Quantitative Real-Time PCR, Methods and Protocols, edited by Roberto Bias soni and Alessandro Raso, Springer Science+13usiness Media, New York, 2014 (https://www.gene-quantification.de/biassoni-raso-quantitative-real-time-per-ebook-2014.pdf).
21 It is to be understood that the methods used in EP 3 164 502 B1 to quantify the expression level of catalase gene in sea lice by quantification of genomic material isolated from a sea lice suspected to be hydrogen peroxidase resistant may be used to quantify the expression level of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glpl_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Although the experimental data linking hydrogen peroxide resistance with the expression level of genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, respectively, were identified in the sea lice species Lepeophtheirus salinonis, the skilled person will acknowledge, based on the teaching herein, that the present method and may be used to determine hydrogen peroxide resistance in copepods belonging to the family Caligidae.
In particular, it is to be understood that the present method may be used to determine hydrogen peroxide resistance in copepods affecting farmed fish, such as e.g.
fish belonging to the family Salmonidae.
According to one embodiment disclosed herein, the present method is applicable for detection of hydrogen peroxide resistance in copepod selected from the group consisting of Lepeophteirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogercresseyi Throughout the disclosure, the term "sea louse" or "sea lice" is to be understood to mean one or more copepod belonging to the family Caligidae. In the experimental data provided in the present disclosure, "sea lice" or "sea louse" refer to the species Lepeophtheirus salmonis.
Based upon the information provided herein in respect of the linkage between hydrogen peroxidase resistance and the expression levels of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, the skilled person would, based on his common general knowledge of the well-known analysis and methods for determining expression levels be able to provide the means necessary to perform such analysis. For example, the skilled person will, based on the teaching herein, identify and construct applicable oligonucleotides, such as probes or primers, useful in the various methods mentioned above.
As used herein, an ''oligonucleotide sequence" or "nucleic acid sequence" is to be understood to mean an oligonucleotide sequence or a nucleic acid sequence useful in determining the expression level of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10, respectively.
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
Although the experimental data linking hydrogen peroxide resistance with the expression level of genes encoding aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, respectively, were identified in the sea lice species Lepeophtheirus salinonis, the skilled person will acknowledge, based on the teaching herein, that the present method and may be used to determine hydrogen peroxide resistance in copepods belonging to the family Caligidae.
In particular, it is to be understood that the present method may be used to determine hydrogen peroxide resistance in copepods affecting farmed fish, such as e.g.
fish belonging to the family Salmonidae.
According to one embodiment disclosed herein, the present method is applicable for detection of hydrogen peroxide resistance in copepod selected from the group consisting of Lepeophteirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi.
According to one aspect the sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus.
According to one aspect the sea lice is Caligus rogercresseyi Throughout the disclosure, the term "sea louse" or "sea lice" is to be understood to mean one or more copepod belonging to the family Caligidae. In the experimental data provided in the present disclosure, "sea lice" or "sea louse" refer to the species Lepeophtheirus salmonis.
Based upon the information provided herein in respect of the linkage between hydrogen peroxidase resistance and the expression levels of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, the skilled person would, based on his common general knowledge of the well-known analysis and methods for determining expression levels be able to provide the means necessary to perform such analysis. For example, the skilled person will, based on the teaching herein, identify and construct applicable oligonucleotides, such as probes or primers, useful in the various methods mentioned above.
As used herein, an ''oligonucleotide sequence" or "nucleic acid sequence" is to be understood to mean an oligonucleotide sequence or a nucleic acid sequence useful in determining the expression level of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10, respectively.
22 An ''oligonucleotide sequence" or "nucleic acid sequence" used to determine the expression level of one or more of the above listed genes is capable of hybridize to a nucleic acid sequence with a complementary sequence, such as e.g. genomic material, extracted from the one or more sea lice to be analyzed for hydrogen peroxide resistance. The skilled person will understand that the genomic material may be e.g. mRNA or DNA.
The skilled person is also aware of the fact that nucleic acid molecules may be double stranded or single-stranded, and that reference to a particular site of one strand refers, as well, to the corresponding site on a complementary strand. Thus, reference to an adenine (A), a thymine (T) (uridine (U)), a cytosine (C) or a guanine (G) at a particular site on one strand of a nucleic acid is also to be understood to define a thymine (uridine), adenine, guanine, or cytosine, respectively, at the corresponding site on a complementary strand of the nucleic acid molecule. Thus, reference may be made to either strand in order to refer to a particular position. The oligonucleotide probes and oligonucleotide primers according to the present invention may be designed to hybridize to either strand.
An "isolated nucleic acid" useful in the detection method of the present invention, i.e. such as primers and probes, as used herein is generally one that contains at least 8 nucleotides and which is capable of hybridizing a nucleic acid with a complementary sequence, and is separated from most other nucleic acids present in the natural source of the nucleic acid, and is thus substantially free of other cellular material.
The present invention provides the use of oligonucleotide probes and oligonucleotide primers being useful in determining the expression level of any one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. The determination of the expression level of a gene is widely applied in both human and veterinary diagnosis, wherein nucleic acids from e.g. pathogens present in biological samples are isolated and hybridized to one or more hybridizing probes or primers are used in order to amplify a target sequence.
One or more oligonucleotide probes may be constructed based on the teaching herein and used in hybridization-based detection methods where upon the binding of the oligonucleotides to the target sequence enables determination of the level of expression of a gene present in the sea lice to be tested.
The skilled person will acknowledge that an oligonucleotide probe according to the present invention may be a fragment of DNA or RNA of variable length used herein in order to hybridize to the target sequence, e.g. single-stranded DNA or RNA. The oligonucleotide probe according to the present invention may furthermore be labeled with a molecular marker in order to easily visualize that hybridization have been achieved.
Molecular markers commonly known to the skilled person may be used, e.g. a radiolabel, and more preferably, a luminescent molecule or a fluorescent molecule enabling the visualisation of the binding of the probe(s) to a target sequence.
An oligonucleotide probe according to the present invention is able to hybridize to another
The skilled person is also aware of the fact that nucleic acid molecules may be double stranded or single-stranded, and that reference to a particular site of one strand refers, as well, to the corresponding site on a complementary strand. Thus, reference to an adenine (A), a thymine (T) (uridine (U)), a cytosine (C) or a guanine (G) at a particular site on one strand of a nucleic acid is also to be understood to define a thymine (uridine), adenine, guanine, or cytosine, respectively, at the corresponding site on a complementary strand of the nucleic acid molecule. Thus, reference may be made to either strand in order to refer to a particular position. The oligonucleotide probes and oligonucleotide primers according to the present invention may be designed to hybridize to either strand.
An "isolated nucleic acid" useful in the detection method of the present invention, i.e. such as primers and probes, as used herein is generally one that contains at least 8 nucleotides and which is capable of hybridizing a nucleic acid with a complementary sequence, and is separated from most other nucleic acids present in the natural source of the nucleic acid, and is thus substantially free of other cellular material.
The present invention provides the use of oligonucleotide probes and oligonucleotide primers being useful in determining the expression level of any one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. The determination of the expression level of a gene is widely applied in both human and veterinary diagnosis, wherein nucleic acids from e.g. pathogens present in biological samples are isolated and hybridized to one or more hybridizing probes or primers are used in order to amplify a target sequence.
One or more oligonucleotide probes may be constructed based on the teaching herein and used in hybridization-based detection methods where upon the binding of the oligonucleotides to the target sequence enables determination of the level of expression of a gene present in the sea lice to be tested.
The skilled person will acknowledge that an oligonucleotide probe according to the present invention may be a fragment of DNA or RNA of variable length used herein in order to hybridize to the target sequence, e.g. single-stranded DNA or RNA. The oligonucleotide probe according to the present invention may furthermore be labeled with a molecular marker in order to easily visualize that hybridization have been achieved.
Molecular markers commonly known to the skilled person may be used, e.g. a radiolabel, and more preferably, a luminescent molecule or a fluorescent molecule enabling the visualisation of the binding of the probe(s) to a target sequence.
An oligonucleotide probe according to the present invention is able to hybridize to another
23 nucleic acid molecule, such as the single strand of DNA or RNA originating from one or more sea lice to be analysed, under appropriate conditions of temperature and solution ionic strength, cf. e.g. Sambrook et al., Molecular Cloning: A laboratory Manual (third edition), 2001, CSHL Press, (ISBN 978-087969577-4). The condition of temperature and ionic strength determine what the skilled person will recognise as the "stringency'' of the hybridization. The suitable stringency for hybridisation of a probe to target nucleic acids depends on inter alia the length of the probe and the degree of complementation, variables well known to the skilled person. A oligonucleotide probe according to the present disclosure typically comprises a nucleotide sequence which under stringent conditions hybridize to at least 8, 10, 12, 14, 16, 18, 20, 22, 25, 30, 40, 50 (or any other number in-between) or more consecutive nucleotides in a target nucleic acid molecule, e.g. single-stranded DNA or RNA isolated from the sea lice to be analyzed according to the present invention. According to one embodiment, the oligonucleotide probe according to the present invention comprises about 10 to 25 consecutive nucleotides. New technology like specific Locked Nucleic Acid (LNA) hybridization probes allows for the use of extremely short oligonucleotide probes (You Y.; Moreira B.G.; Behlke M.A. and Owczarzy R.
(2006). "Design of LNA probes that improve mismatch discrimination". Nucleic Acids Res. 34(8): e60. doi:10.1093/narigk1 1 75. PMC 1456327. PMTD 16670427) According to one embodiment, probes are used in the present method or according to the present use, which hybridize under stringent conditions to a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID
No. 10.
Also oligonucleotide primers may be used in methods according to the present method for determination of the expression level of a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10, wherein the oligonucleotide primers are used for amplification of any given region of said genes. An oligonucleotide primer according to the present disclosure typically comprises a nucleotide sequence at least 8, 10, 12, 14, 16, 18, 20, 22, 25, 30, 40, 50 (or any other number in-between) or more consecutive nucleotides. According to one embodiment, the oligonucicotide primer according to the present invention comprises about consecutive nucleotides, more preferably about 15 nucleotides.
As used herein, the term "oligonucleotide primer'' is to be understood to refer to a nucleic acid sequence suitable for directing an activity to a region of a nucleic acid, e.g. for amplification of a target nucleic acid sequence by polymerase chain reaction (PCR).
The skilled person will acknowledge that an oligonucleotide primer according to the present invention may be a fragment of DNA or RNA of variable length used herein in order to determine the expression level of the target sequence, e.g. single-stranded DNA or RNA, upon alignment of the oligonucleotide probe to complementary sequence(s) of the said target sequence to be analyzed. An oligonucleotide primer according to the present invention may furthermore be labeled with a molecular marker in order to enable visualization of the results obtained. Various molecular markers or labels are available. An
(2006). "Design of LNA probes that improve mismatch discrimination". Nucleic Acids Res. 34(8): e60. doi:10.1093/narigk1 1 75. PMC 1456327. PMTD 16670427) According to one embodiment, probes are used in the present method or according to the present use, which hybridize under stringent conditions to a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID
No. 10.
Also oligonucleotide primers may be used in methods according to the present method for determination of the expression level of a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ
ID No.
10, wherein the oligonucleotide primers are used for amplification of any given region of said genes. An oligonucleotide primer according to the present disclosure typically comprises a nucleotide sequence at least 8, 10, 12, 14, 16, 18, 20, 22, 25, 30, 40, 50 (or any other number in-between) or more consecutive nucleotides. According to one embodiment, the oligonucicotide primer according to the present invention comprises about consecutive nucleotides, more preferably about 15 nucleotides.
As used herein, the term "oligonucleotide primer'' is to be understood to refer to a nucleic acid sequence suitable for directing an activity to a region of a nucleic acid, e.g. for amplification of a target nucleic acid sequence by polymerase chain reaction (PCR).
The skilled person will acknowledge that an oligonucleotide primer according to the present invention may be a fragment of DNA or RNA of variable length used herein in order to determine the expression level of the target sequence, e.g. single-stranded DNA or RNA, upon alignment of the oligonucleotide probe to complementary sequence(s) of the said target sequence to be analyzed. An oligonucleotide primer according to the present invention may furthermore be labeled with a molecular marker in order to enable visualization of the results obtained. Various molecular markers or labels are available. An
24 oligonucleotide primer according to the present invention typically comprises the appropriate number of nucleotides allowing that said primer align with the target sequence to he analyzed.
Oligonucleotide probes and oligonucleotide primers may be manufactured according to methods well known to the skilled person.
According to one aspect, oligonucleotides (primers or probes) may be used determine the expression level of a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to yet another aspect, oligonucleotides (primers or probes) may be used to determine the expression level of nucleic acid molecule comprising a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID NO. 5, SEQ ID No. 7 and SEQ
ID No.
9 or variants or fragments thereof having at least 70% identity with SEQ ID
No. 1, SEQ ID
No. 3, SEQ ID NO. 5, SEQ ID No. 7 and SEQ ID No. 9, respectively.
The term "% identity' is to be understood to refer to the percentage of nucleotides that two or more sequences or fragments thereof contains, that are the same. A
specified percentage of nucleotides can be referred to as e.g. 70% identity, 75% identity, 80%
identity, 85%
identity, 90% identity, 95% identity, 99% identity or more (or any number in between) over a specified region when compared and aligned for maximum correspondence.
The skilled person will acknowledge that various means for comparing sequences are available. For example, one non-limiting example of a useful computer homology or identity program useful for determining the percent sequence identity between sequences includes the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990, J. of Molec. Biol., 215:403-410, "The BLAST Algorithm; Altschul et al., 1997, Nuc.
Acids Res. 25:3389-3402, Karlin and Altschul 1990, Proc. Nat'l Acad. Sci. USA, 87:2264-68 ;
1993, Proc. Nat'l Acad. Sci. USA 90:5873-77).
Isolation of genomic material of sea lice The method according to the present invention may according to one embodiment involve the isolation of a biological sample from one or more sea lice and measuring the level of expression of the genes of interest in order to determine whether the sea lice is hydrogen peroxide resistant.
Various methods for obtaining genomic material well known to the skilled person are available. The skilled person will acknowledge that any tissue (i.e. any part of the sea lice) may be used in order to extract genomic material. Furthermore, the genomic material to be analyzed according to the present invention may be obtained from sea lice of any life stages, e.g. the free-swimming stages (nauplius stage I and II), the copepod stage, the pre-adult (chalimus stages 1-4), or the adult stage (adult male or adult female).
In one embodiment, the sea lice are adult female.
According to one embodiment, tissue removed from sea lice to be tested is maintained in 70% ethanol or other conservation liquid prior to further isolation of genomic material.
DNA may be extracted from the obtained tissue using commonly available DNA
extraction/isolation methods, such as e.g. DNeasy DNA Tissue Kit according to the 5 protocol of the manufacturer (http://lycofs01.1ycoming.edu/¨gcat-scck/protocols/DNcasy_Blood_&_Tissue_Handbook.pdf ).
Hydrogen peroxidase resistance kits Based on the teaching herein, the skilled person will acknowledge that the identification of 10 the link between hydrogen peroxide resistance and expression levels of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, in sea lice, reagents applicable in determination of the expression level of said genes can be developed for the determination of hydrogen 15 peroxidase resistance.
For example, according to the present invention, a kit may comprise oligonucleotide probe(s) or oligonucleotide primer(s) or primer sets, arrays/microarrays of nucleic acid molecules, and beads that contain one more oligonucleotide probe(s), oligonucleotide primer(s) or other detection reagents useful in the method of the present invention. It is 20 furthermore to he understood that the detection reagents in a kit according to the present invention may furthermore include other components commonly included in such kits, e.g.
such as various types of biochemical reagents (buffers. DNA polymerase, ligase, deoxynucleotide triphosphates for chain extension/amplification, etc.), containers, packages, substrates to which detection reagents are attached., etc. necessary to carry the
Oligonucleotide probes and oligonucleotide primers may be manufactured according to methods well known to the skilled person.
According to one aspect, oligonucleotides (primers or probes) may be used determine the expression level of a gene encoding a protein selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA
polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
According to yet another aspect, oligonucleotides (primers or probes) may be used to determine the expression level of nucleic acid molecule comprising a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID NO. 5, SEQ ID No. 7 and SEQ
ID No.
9 or variants or fragments thereof having at least 70% identity with SEQ ID
No. 1, SEQ ID
No. 3, SEQ ID NO. 5, SEQ ID No. 7 and SEQ ID No. 9, respectively.
The term "% identity' is to be understood to refer to the percentage of nucleotides that two or more sequences or fragments thereof contains, that are the same. A
specified percentage of nucleotides can be referred to as e.g. 70% identity, 75% identity, 80%
identity, 85%
identity, 90% identity, 95% identity, 99% identity or more (or any number in between) over a specified region when compared and aligned for maximum correspondence.
The skilled person will acknowledge that various means for comparing sequences are available. For example, one non-limiting example of a useful computer homology or identity program useful for determining the percent sequence identity between sequences includes the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990, J. of Molec. Biol., 215:403-410, "The BLAST Algorithm; Altschul et al., 1997, Nuc.
Acids Res. 25:3389-3402, Karlin and Altschul 1990, Proc. Nat'l Acad. Sci. USA, 87:2264-68 ;
1993, Proc. Nat'l Acad. Sci. USA 90:5873-77).
Isolation of genomic material of sea lice The method according to the present invention may according to one embodiment involve the isolation of a biological sample from one or more sea lice and measuring the level of expression of the genes of interest in order to determine whether the sea lice is hydrogen peroxide resistant.
Various methods for obtaining genomic material well known to the skilled person are available. The skilled person will acknowledge that any tissue (i.e. any part of the sea lice) may be used in order to extract genomic material. Furthermore, the genomic material to be analyzed according to the present invention may be obtained from sea lice of any life stages, e.g. the free-swimming stages (nauplius stage I and II), the copepod stage, the pre-adult (chalimus stages 1-4), or the adult stage (adult male or adult female).
In one embodiment, the sea lice are adult female.
According to one embodiment, tissue removed from sea lice to be tested is maintained in 70% ethanol or other conservation liquid prior to further isolation of genomic material.
DNA may be extracted from the obtained tissue using commonly available DNA
extraction/isolation methods, such as e.g. DNeasy DNA Tissue Kit according to the 5 protocol of the manufacturer (http://lycofs01.1ycoming.edu/¨gcat-scck/protocols/DNcasy_Blood_&_Tissue_Handbook.pdf ).
Hydrogen peroxidase resistance kits Based on the teaching herein, the skilled person will acknowledge that the identification of 10 the link between hydrogen peroxide resistance and expression levels of genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10, in sea lice, reagents applicable in determination of the expression level of said genes can be developed for the determination of hydrogen 15 peroxidase resistance.
For example, according to the present invention, a kit may comprise oligonucleotide probe(s) or oligonucleotide primer(s) or primer sets, arrays/microarrays of nucleic acid molecules, and beads that contain one more oligonucleotide probe(s), oligonucleotide primer(s) or other detection reagents useful in the method of the present invention. It is 20 furthermore to he understood that the detection reagents in a kit according to the present invention may furthermore include other components commonly included in such kits, e.g.
such as various types of biochemical reagents (buffers. DNA polymerase, ligase, deoxynucleotide triphosphates for chain extension/amplification, etc.), containers, packages, substrates to which detection reagents are attached., etc. necessary to carry the
25 method according to the present invention.
According to one embodiment of the present invention, a kit is provided which comprises the necessary reagents to carry out one or more assays in order to determine the catalase gene expression level according to the method of the present invention. A kit according to the present invention may preferably comprise one or more oligonucleotide probes that hybridize to a nucleic acid target molecule (i.e. genetic material) enabling determination of the catalase gene expression level in the material analyzed. Multiple pairs of probes may be included in the kit to simultaneously analyze for determination of catalase gene expression at the same time. The probes contained in the kit according to the present invention may according to one embodiment be immobilized on a carrier, such as e.g. an array or a bead.
According to one embodiment, a kit according to the present invention comprises oligonucleotide primer(s) and optionally further reagents useful in methods for the determination of the expression level of one or more of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp 1 v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. According to one embodiment, the kit according to the present invention comprises a forward primer and a reverse primer for amplifying a region of one or more of said genes. Said kit may furthermore optionally comprise further reagents (enzymes and nucleotide triphosphates) necessary for conducting PCR or real time PCR.
According to one embodiment of the present invention, a kit is provided which comprises the necessary reagents to carry out one or more assays in order to determine the catalase gene expression level according to the method of the present invention. A kit according to the present invention may preferably comprise one or more oligonucleotide probes that hybridize to a nucleic acid target molecule (i.e. genetic material) enabling determination of the catalase gene expression level in the material analyzed. Multiple pairs of probes may be included in the kit to simultaneously analyze for determination of catalase gene expression at the same time. The probes contained in the kit according to the present invention may according to one embodiment be immobilized on a carrier, such as e.g. an array or a bead.
According to one embodiment, a kit according to the present invention comprises oligonucleotide primer(s) and optionally further reagents useful in methods for the determination of the expression level of one or more of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (Glp 1 v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10. According to one embodiment, the kit according to the present invention comprises a forward primer and a reverse primer for amplifying a region of one or more of said genes. Said kit may furthermore optionally comprise further reagents (enzymes and nucleotide triphosphates) necessary for conducting PCR or real time PCR.
26 Examples Salmon louse strains Two well-characterized laboratory L. sahnonis strains were used in this study:
Ls A, sensitive to all anti-salmon lice chemicals used in Norway (tested by bioassays), and Ls V, resistant to azamethiphos, deltamethrin, emamectin benzoate and hydrogen peroxide (field reports and bioassays). Ls A was a strain originally collected on a fish farm in the Northern part of Norway in 2011. Ls V was collected from a fish farm in Mid-Norway in October 2013 with high anti-louse chemical treatment pressure and reported diminished treatment efficacy. A total of 14 anti-louse chemical treatments were performed from August 2012 to September 2013 in that farm: six H202 treatments (up until one month before the lice collection), six combined treatments with deltamethrin and azamethiphos, one treatment with diflubenzuron and one with emamectin benzoate. The Ls V-samples referred to in the current study were the original field samples of this strain. Ls A
and Ls V strains were reared in continuous cultures at the research facilities of Solbergstrand (The Norwegian Institute for Water Research, NIVA, DrOak, Norway), as described by Hamre et al. (2009), in "Establishment and characterization of salmon louse (Lepeophtheirus salmonis (Kroyer 1837)) laboratory strains". Parasitol. Int.
58, 451-460 Example 1 Crossing experiment and bioassays In order to obtain a lice sample from the same generation and a range of hydroxy peroxide sensitivities, a batch crossing experiment was designed. The experiment was performed as described by Bakke et al. (2018) in 2015 (Bakke et at., (2018), Deltamethrin resistance in the salmon louse, Lepeophtheirus salmonis (Kroyer): Maternal inheritance and reduced apoptosis", Scientific Reports 8, Article number: 8450).
In short, two Atlantic salmon (one fish per aquarium) were infested with approximately 50 Ls A copepodites each and another two fish (one fish per aquarium) with the same number of Ls V copepodites to produce the parental generation (PO). All salmon lice were collected from all fish when the lice were in the pre-adult II stage, before the mating occurred. Then 10 pre-adults II Ls A females and 10 pre-adult II Ls V males from the PO
generation were put back on 2 individual fish (5 on each fish) kept in individual tanks to produce the Fl generation of the family group 1. Two other fish in separate tanks were infested with the same number of Ls A males and Ls V females to produce the Fl generation of family group 2. All PO lice from both family groups were preserved in RNAlater (Sigma) after removal of the egg strings which were set aside to hatch. After ¨24h at room-temperature. the preserved samples were stored at ¨80 C. Four fish were infested with copepodites from the Fl generation, two fish with family group 1 and two fish with family group 2. The lice developed to the adult stage, mated, and egg strings for the F2 generation were collected.
Approximately 500 copepodites from each of the family groups 1 and 2 (F2) were used for infestation of eight Atlantic salmon for each family group, with the two-family groups separated in different tanks.
F2 parasites were allowed to develop to adults. and were selected for sensitivity towards hydrogen peroxide (Interox Paramove 50, H20250%, w/w, Solvay Chemicals, Belgium).
The selection was performed in vitro using two-dose bioassays at Faculty of Veterinary
Ls A, sensitive to all anti-salmon lice chemicals used in Norway (tested by bioassays), and Ls V, resistant to azamethiphos, deltamethrin, emamectin benzoate and hydrogen peroxide (field reports and bioassays). Ls A was a strain originally collected on a fish farm in the Northern part of Norway in 2011. Ls V was collected from a fish farm in Mid-Norway in October 2013 with high anti-louse chemical treatment pressure and reported diminished treatment efficacy. A total of 14 anti-louse chemical treatments were performed from August 2012 to September 2013 in that farm: six H202 treatments (up until one month before the lice collection), six combined treatments with deltamethrin and azamethiphos, one treatment with diflubenzuron and one with emamectin benzoate. The Ls V-samples referred to in the current study were the original field samples of this strain. Ls A
and Ls V strains were reared in continuous cultures at the research facilities of Solbergstrand (The Norwegian Institute for Water Research, NIVA, DrOak, Norway), as described by Hamre et al. (2009), in "Establishment and characterization of salmon louse (Lepeophtheirus salmonis (Kroyer 1837)) laboratory strains". Parasitol. Int.
58, 451-460 Example 1 Crossing experiment and bioassays In order to obtain a lice sample from the same generation and a range of hydroxy peroxide sensitivities, a batch crossing experiment was designed. The experiment was performed as described by Bakke et al. (2018) in 2015 (Bakke et at., (2018), Deltamethrin resistance in the salmon louse, Lepeophtheirus salmonis (Kroyer): Maternal inheritance and reduced apoptosis", Scientific Reports 8, Article number: 8450).
In short, two Atlantic salmon (one fish per aquarium) were infested with approximately 50 Ls A copepodites each and another two fish (one fish per aquarium) with the same number of Ls V copepodites to produce the parental generation (PO). All salmon lice were collected from all fish when the lice were in the pre-adult II stage, before the mating occurred. Then 10 pre-adults II Ls A females and 10 pre-adult II Ls V males from the PO
generation were put back on 2 individual fish (5 on each fish) kept in individual tanks to produce the Fl generation of the family group 1. Two other fish in separate tanks were infested with the same number of Ls A males and Ls V females to produce the Fl generation of family group 2. All PO lice from both family groups were preserved in RNAlater (Sigma) after removal of the egg strings which were set aside to hatch. After ¨24h at room-temperature. the preserved samples were stored at ¨80 C. Four fish were infested with copepodites from the Fl generation, two fish with family group 1 and two fish with family group 2. The lice developed to the adult stage, mated, and egg strings for the F2 generation were collected.
Approximately 500 copepodites from each of the family groups 1 and 2 (F2) were used for infestation of eight Atlantic salmon for each family group, with the two-family groups separated in different tanks.
F2 parasites were allowed to develop to adults. and were selected for sensitivity towards hydrogen peroxide (Interox Paramove 50, H20250%, w/w, Solvay Chemicals, Belgium).
The selection was performed in vitro using two-dose bioassays at Faculty of Veterinary
27 Medicine, NMBU (University of Life Sciences, Oslo, Norway) within 6 hours after sampling. All exposures were done in 1 L glass bottles held at 10-12 C with constant aeration. Three bioassays were performed where the females were exposed to 600 and 1800 ppm 11202 for 30 min (two bioassays with lice from the family group 1 and one from family group 2) and recording of the results immediately following the exposure time (Helges en et al., (2015), supra).
Control groups not exposed to H202 were included to check the general performance of the parasites. Parasites affected/immobilized at the lowest H202 concentrations were considered sensitive, whereas parasites that were not visibly affected at the highest concentrations were considered resistant. Lice were classified as affected when they were unable to attach to the container wall (lice could show weak swimming pattern, being partially or completely immobilized at the bottom of the container at floating at the surface). Immediately after exposure and the immobilization rate recorded, lice were fixed in RNAlater and kept at ¨80 C following ¨24h at room-temperature. H202 sensitive and resistant F2 adult females were used in the RNAseq analysis.
In order to obtain H202 sensitive and resistant lice for the RNAseq study, F2 adult females were selected with two-dose H202 bioassays. Lice affected at the lowest dose were considered sensitive and lice unaffected at the highest were considered resistant. Table 1 shows the number of lice affected at the different 14202 doses. For adult females, there were no significant differences between family groups, indicating that inheritance of resistance was not gender-specific.
Table 1. Number of F2 adult female lice affected in two-dose H202 bioassays (30 min exposure). Results indicated as fractions (number of affected lice out of total lice per dose) and percentages (in brackets) Crossing and bioassays Family group 1 Family group 1 Family group 0 ppm (Control) 1/18 (6 %) 0/5 (0 %) 1/18 (6 %) 600 ppm 2/16 (13 %) 1/18 (6 %) 8/32 (25 %) 1800 ppm 13/15 (87 %) 12/18 (67 %) 16/25 (64 %) Family group 1: females from the sensitive Ls A strain were crossed with males from the H202-resistant Ls V strain in the PO generation. Family group 2: males from the sensitive Ls A strain were crossed with females from the H202-resistant Ls V strain in the PO
generation.
Example 2 Transcriptome analysis In total, 36 adult female parasites were enrolled. From the original strains (2013), four laboratory reared Ls A and five field collected Ls V were used. From the PO
generation for the batch crossing experiment (2015), three Ls A and four Ls V parasites were included.
None of these parasites were selected for sensitivity towards any agent prior to sampling.
Control groups not exposed to H202 were included to check the general performance of the parasites. Parasites affected/immobilized at the lowest H202 concentrations were considered sensitive, whereas parasites that were not visibly affected at the highest concentrations were considered resistant. Lice were classified as affected when they were unable to attach to the container wall (lice could show weak swimming pattern, being partially or completely immobilized at the bottom of the container at floating at the surface). Immediately after exposure and the immobilization rate recorded, lice were fixed in RNAlater and kept at ¨80 C following ¨24h at room-temperature. H202 sensitive and resistant F2 adult females were used in the RNAseq analysis.
In order to obtain H202 sensitive and resistant lice for the RNAseq study, F2 adult females were selected with two-dose H202 bioassays. Lice affected at the lowest dose were considered sensitive and lice unaffected at the highest were considered resistant. Table 1 shows the number of lice affected at the different 14202 doses. For adult females, there were no significant differences between family groups, indicating that inheritance of resistance was not gender-specific.
Table 1. Number of F2 adult female lice affected in two-dose H202 bioassays (30 min exposure). Results indicated as fractions (number of affected lice out of total lice per dose) and percentages (in brackets) Crossing and bioassays Family group 1 Family group 1 Family group 0 ppm (Control) 1/18 (6 %) 0/5 (0 %) 1/18 (6 %) 600 ppm 2/16 (13 %) 1/18 (6 %) 8/32 (25 %) 1800 ppm 13/15 (87 %) 12/18 (67 %) 16/25 (64 %) Family group 1: females from the sensitive Ls A strain were crossed with males from the H202-resistant Ls V strain in the PO generation. Family group 2: males from the sensitive Ls A strain were crossed with females from the H202-resistant Ls V strain in the PO
generation.
Example 2 Transcriptome analysis In total, 36 adult female parasites were enrolled. From the original strains (2013), four laboratory reared Ls A and five field collected Ls V were used. From the PO
generation for the batch crossing experiment (2015), three Ls A and four Ls V parasites were included.
None of these parasites were selected for sensitivity towards any agent prior to sampling.
28 From the F2 generation after the crossing experiment, 20 parasites were included. These were selected for sensitivity towards H202, prior to sampling. Additional details are given in Table 2.
Table 2. Information about the 36 samples (all adult female lice) enrolled in the RNAseq study. N, sample size.
Group N Description Laboratory strain, sensitive to all delousing chemicals. Collected in Northern Norway Ls A-2013 4 in 2011. Sixth generation.
Field strain, resistant to azamethiphos, deltamethrin, emamectin benzoate and Ls V-2013 5 hydrogen peroxide_ Collected in Mid-Norway in 2013.
Laboratory strain. 12th generation of Ls A (sensitive). Not exposed to delousing Ls A-PO 3 chemicals during cultivation of any generation.
Laboratory strain. Sixth generation of Ls V (resistant). Not exposed to delousing Ls V-PO 4 chemicals during cultivation of any generation.
Second generation after crossing of Ls A-PO and Ls V-PO, affected by 600 ppm }1)07 Ls F
8 for 30 min (sensitive). Three lice from family group 1 and five lice from family group 2.
Second generation after crossing of Ls A-PO and Ls V-PO, unaffected by 1800 ppin Ls F2-12 H202 for 30 min (resistant). Seven lice from family group 1 and five lice from family group 2.
RNA extraction Total RNA was extracted from the 36 individual adult females using a Trizol protocol combined with RNeasy Mini kit for animal tissues (Qiagen, CA, USA) (one individual per extraction). Lice tissues were disrupted and homogenized in 1 ml Trizol using TissueLyser MM 301 (Qiagen Retsch) and one stainless steel bead of 5 mm diameter (Qiagen).
After mixing with 0.2 ml of chloroform and a centrifugation step, the aqueous phase was transferred to a new vial and mixed with one volume of 70% ethanol. Total RNA
was then isolated with RNeasy spin columns following manufacturer's protocol. Genomic DNA was removed from the extracted RNA (10 lag) with Turbo DNA-free TM kit (TURBOTm DNase Treatment and Removal Reagents, Ambion, Life Technologies Thermo Fisher Scientific, USA). Subsequently, the RNA was cleaned and concentrated with RNA Clean &
ConcentratorTM-5 (Zymo Research). The RNA was quantified with ND-100 Spectrophotometer (Thermo Fisher Scientific, DE, USA) and the quality was checked with a 2100 Bioanalyzer instrument (Agilent Technologies) and the Agilent RNA 6000 Nano kit.
Table 2. Information about the 36 samples (all adult female lice) enrolled in the RNAseq study. N, sample size.
Group N Description Laboratory strain, sensitive to all delousing chemicals. Collected in Northern Norway Ls A-2013 4 in 2011. Sixth generation.
Field strain, resistant to azamethiphos, deltamethrin, emamectin benzoate and Ls V-2013 5 hydrogen peroxide_ Collected in Mid-Norway in 2013.
Laboratory strain. 12th generation of Ls A (sensitive). Not exposed to delousing Ls A-PO 3 chemicals during cultivation of any generation.
Laboratory strain. Sixth generation of Ls V (resistant). Not exposed to delousing Ls V-PO 4 chemicals during cultivation of any generation.
Second generation after crossing of Ls A-PO and Ls V-PO, affected by 600 ppm }1)07 Ls F
8 for 30 min (sensitive). Three lice from family group 1 and five lice from family group 2.
Second generation after crossing of Ls A-PO and Ls V-PO, unaffected by 1800 ppin Ls F2-12 H202 for 30 min (resistant). Seven lice from family group 1 and five lice from family group 2.
RNA extraction Total RNA was extracted from the 36 individual adult females using a Trizol protocol combined with RNeasy Mini kit for animal tissues (Qiagen, CA, USA) (one individual per extraction). Lice tissues were disrupted and homogenized in 1 ml Trizol using TissueLyser MM 301 (Qiagen Retsch) and one stainless steel bead of 5 mm diameter (Qiagen).
After mixing with 0.2 ml of chloroform and a centrifugation step, the aqueous phase was transferred to a new vial and mixed with one volume of 70% ethanol. Total RNA
was then isolated with RNeasy spin columns following manufacturer's protocol. Genomic DNA was removed from the extracted RNA (10 lag) with Turbo DNA-free TM kit (TURBOTm DNase Treatment and Removal Reagents, Ambion, Life Technologies Thermo Fisher Scientific, USA). Subsequently, the RNA was cleaned and concentrated with RNA Clean &
ConcentratorTM-5 (Zymo Research). The RNA was quantified with ND-100 Spectrophotometer (Thermo Fisher Scientific, DE, USA) and the quality was checked with a 2100 Bioanalyzer instrument (Agilent Technologies) and the Agilent RNA 6000 Nano kit.
29 RNAseq Total RNA samples wcrc used for library preparation and Illumina sequencing at the Norwegian Sequencing Centre (Oslo, Norway). Thirty-six RNA-seq libraries (one per individual lice), each with unique index barcodes, were prepared using the TruSeq Stranded total RNA library preparation Kit v2 (I1lumina. USA) by following manufacturer's protocol including the polyA enrichment step. Libraries were pooled together and sequenced on NextSeq500 platform (Illumina, USA) using 150 bp paired end High output reagents. Raw bel files were generated using RTA v2.4.11 and were later demultiplexed (using the sample specific index) and converted to fastq format using bc12fastq v2.17.1.14.
RNAseq gene expression analysis (DESeq2) showed that the groups Ls V-2013 and Ls F2-H202-R each had more than 2000 genes differentially regulated compared to the corresponding, presumably sensitive groups, Ls A-2013 and Ls-F2- H202-S. The Ls V-PO
lice had less than 150 genes differentially regulated compared to Ls A-PO
(Fig. 2).
Example 3: Gene expression analysis Demultiplexed raw reads were cleaned using Trimmomatic v0.33 (Bolger et al..
2014, "Trimmomatic: a flexible trimmer for Illumina sequence data", Bioinformatics
RNAseq gene expression analysis (DESeq2) showed that the groups Ls V-2013 and Ls F2-H202-R each had more than 2000 genes differentially regulated compared to the corresponding, presumably sensitive groups, Ls A-2013 and Ls-F2- H202-S. The Ls V-PO
lice had less than 150 genes differentially regulated compared to Ls A-PO
(Fig. 2).
Example 3: Gene expression analysis Demultiplexed raw reads were cleaned using Trimmomatic v0.33 (Bolger et al..
2014, "Trimmomatic: a flexible trimmer for Illumina sequence data", Bioinformatics
30, 2114-2120) to remove/trim low quality reads and sequencing adapters as well as using BBMap v34.56 (https://sourceforge.net/projects/bbmap/) to remove reads mapping to PhiX genome (Illumina spike-in). Cleaned fastq reads for each parasite were aligned to the L. salmonis transcriptome (coding sequences) using Hisat2 v2.1.0 (Kim et al., 2015, "HISAT: a fast-spliced aligner with low memory requirements", Nature Methods 12, 357-360.
https://www.nature.com/articles/nmeth.3317). The transcriptome file (ftp://ftp.ensemblgenomes.org/pub/metazoakelease-44/fasta/lepeophtheirus_salmonis) contained the predicted transcriptome from genomic data. It was modified for the aquaporin genes by substituting the predicted cds sequences in the original transcriptome with experimentally determined cds sequences from Stavang et al. (2015), supra.
Unmapped reads were filtered out using SAMtools version 1.4 (Li et al., 2009, The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079).
Gene annotation files in GTF format were generated for each parasite and then mcrgcd using Cufflinks version 2.2.1. (Trapnell et al., 2010, -Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation". Nat. Biotechnol. 28, 511-515). Counts of fragments aligning to each transcript were calculated using FeatureCounts version 1.5.2. (Liao et al., 2014, "FeatureCounts: an efficient general-purpose program for assigning sequence reads to genomic features", Bioinformatics 30, 923-930). Analysis of the differential expression within each group (Ls A-2013 versus Ls V-2013; Ls A-PO versus Ls V-PO; Ls F2-versus Ls H,07-R) were done using DESN2 (Love et al., "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2-, Genome Biol. 15, 550) (default settings for the count normalization method). The significance level was set to a = 0.05.
Differentially expressed genes shared between presumed hydrogen peroxide resistant lice Thc DESeq2 analysis generated two lists for each group, one list of genes up-regulated in resistant lice and another list for genes down-regulated in resistant lice, both compared to sensitive lice within the same group. We searched for genes that were differentially 5 expressed in the same direction in at least two of the three groups. An R
-script was developed to identify the shared genes across all the groups (Ls 2013, Ls PO
and Ls F2-1-1202) or between two of the groups (Ls 2013 vs Ls PO, Ls 2013 vs Ls F2- H202 and Ls PO
vs Ls F2- H202). The Uniprot database (www.uniprot.org), NCBI-Non-redundant protein sequences (nr) database (ncbi.nlm.nih.gov) and "ENSEMBL Metazoa (transcript)-10 "protein information" section (http://rnetazoa.ensembLorg/Lepeophtheirus_salmonis/Info/Index), were used to annotate the genes.
qPCR study 15 Quantitative polymerase chain reaction (qPCR) was used to validate the RNAseq results for two genes, catalase and Glpl_v2. An elevated expression of catalase has already been associated with resistance towards hydrogen peroxide (Helgesen et al. (2017), "Increased catalase activity ___________ A possible resistance mechanism in hydrogen peroxide resistant salmon lice (Lepeophtheirus salmonis)", Aquaculture, 468 (1), 135-140), and the expression of 20 G1p1_v2 was significantly downregulated in the three groups of presumed H20,-resistant parasites in the RNAseq study (Ls V-2013, Ls V-PO, Ls F2- H202-R). The samples enrolled in the validation study were not exposed adult females from the RNAseq study:
Ls A-2013, Ls V-2013, Ls A-P0 and Ls V-PO.
RNA extraction, DNase treatment and RNA cleaning were performed for every sample the 25 same way as samples prepared for RNAseq. First strand cDNA was produced from 1 iug of cleaned RNA using the qScriptTM cDNA synthesis (reverse transcriptase) kit (Quanta Biosciences, MD, USA). The cDNA was cleaned with the DNA Clean &
ConcentratorTM5 kit (Zymo Research) and diluted 1:10 before used as PCR template for qPCR
using gene specific primers and SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, CA, USA), 30 following manufacturer's protocol. Each qPCR reaction was optimized for 11 1 total reaction volume, 150/150 or 300/300 nM primer concentration and 2 In of template, corresponding to 0.2 lig cDNA/RNA. Reactions were run in duplicate or triplicate and two negative controls were added, a non-template control and a no reverse transcriptase control.
The range of efficiencies for qPCR reactions were 96-98% for reference and gene specific primers. The qPCR was run on a Bio-Rad CFX96 real-time system (Bio-Rad, CA, USA) under the following conditions: 95 C for 30 sec followed by 40 cycles of amplification at 95 C for 10 sec and 60 C for 50 sec. After qPCR, the homogeneity and specificity of the PCR products was confirmed by melting curve analysis, agarosc gel electrophoresis and Sanger sequencing. Relative gene expression was determined by the ACt method (ACt =
Otarget Ctreference), where Cttarget is the Ct values for catalase or Glp1_v2, and Ctreterence the average of the elongation factor 1-alpha (EF) and prohibitin-2 (Proh2) genes.
(see table 3 below for primer details). Fold change in gene expression was calculated according to the 2^-(AACt) method, using the average of the Ct values for Ls A-2013 and Ls A-PO
lice as calibrator sample. Expression levels (ACt) of catalase and Glp1_v2 were separately
https://www.nature.com/articles/nmeth.3317). The transcriptome file (ftp://ftp.ensemblgenomes.org/pub/metazoakelease-44/fasta/lepeophtheirus_salmonis) contained the predicted transcriptome from genomic data. It was modified for the aquaporin genes by substituting the predicted cds sequences in the original transcriptome with experimentally determined cds sequences from Stavang et al. (2015), supra.
Unmapped reads were filtered out using SAMtools version 1.4 (Li et al., 2009, The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079).
Gene annotation files in GTF format were generated for each parasite and then mcrgcd using Cufflinks version 2.2.1. (Trapnell et al., 2010, -Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation". Nat. Biotechnol. 28, 511-515). Counts of fragments aligning to each transcript were calculated using FeatureCounts version 1.5.2. (Liao et al., 2014, "FeatureCounts: an efficient general-purpose program for assigning sequence reads to genomic features", Bioinformatics 30, 923-930). Analysis of the differential expression within each group (Ls A-2013 versus Ls V-2013; Ls A-PO versus Ls V-PO; Ls F2-versus Ls H,07-R) were done using DESN2 (Love et al., "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2-, Genome Biol. 15, 550) (default settings for the count normalization method). The significance level was set to a = 0.05.
Differentially expressed genes shared between presumed hydrogen peroxide resistant lice Thc DESeq2 analysis generated two lists for each group, one list of genes up-regulated in resistant lice and another list for genes down-regulated in resistant lice, both compared to sensitive lice within the same group. We searched for genes that were differentially 5 expressed in the same direction in at least two of the three groups. An R
-script was developed to identify the shared genes across all the groups (Ls 2013, Ls PO
and Ls F2-1-1202) or between two of the groups (Ls 2013 vs Ls PO, Ls 2013 vs Ls F2- H202 and Ls PO
vs Ls F2- H202). The Uniprot database (www.uniprot.org), NCBI-Non-redundant protein sequences (nr) database (ncbi.nlm.nih.gov) and "ENSEMBL Metazoa (transcript)-10 "protein information" section (http://rnetazoa.ensembLorg/Lepeophtheirus_salmonis/Info/Index), were used to annotate the genes.
qPCR study 15 Quantitative polymerase chain reaction (qPCR) was used to validate the RNAseq results for two genes, catalase and Glpl_v2. An elevated expression of catalase has already been associated with resistance towards hydrogen peroxide (Helgesen et al. (2017), "Increased catalase activity ___________ A possible resistance mechanism in hydrogen peroxide resistant salmon lice (Lepeophtheirus salmonis)", Aquaculture, 468 (1), 135-140), and the expression of 20 G1p1_v2 was significantly downregulated in the three groups of presumed H20,-resistant parasites in the RNAseq study (Ls V-2013, Ls V-PO, Ls F2- H202-R). The samples enrolled in the validation study were not exposed adult females from the RNAseq study:
Ls A-2013, Ls V-2013, Ls A-P0 and Ls V-PO.
RNA extraction, DNase treatment and RNA cleaning were performed for every sample the 25 same way as samples prepared for RNAseq. First strand cDNA was produced from 1 iug of cleaned RNA using the qScriptTM cDNA synthesis (reverse transcriptase) kit (Quanta Biosciences, MD, USA). The cDNA was cleaned with the DNA Clean &
ConcentratorTM5 kit (Zymo Research) and diluted 1:10 before used as PCR template for qPCR
using gene specific primers and SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, CA, USA), 30 following manufacturer's protocol. Each qPCR reaction was optimized for 11 1 total reaction volume, 150/150 or 300/300 nM primer concentration and 2 In of template, corresponding to 0.2 lig cDNA/RNA. Reactions were run in duplicate or triplicate and two negative controls were added, a non-template control and a no reverse transcriptase control.
The range of efficiencies for qPCR reactions were 96-98% for reference and gene specific primers. The qPCR was run on a Bio-Rad CFX96 real-time system (Bio-Rad, CA, USA) under the following conditions: 95 C for 30 sec followed by 40 cycles of amplification at 95 C for 10 sec and 60 C for 50 sec. After qPCR, the homogeneity and specificity of the PCR products was confirmed by melting curve analysis, agarosc gel electrophoresis and Sanger sequencing. Relative gene expression was determined by the ACt method (ACt =
Otarget Ctreference), where Cttarget is the Ct values for catalase or Glp1_v2, and Ctreterence the average of the elongation factor 1-alpha (EF) and prohibitin-2 (Proh2) genes.
(see table 3 below for primer details). Fold change in gene expression was calculated according to the 2^-(AACt) method, using the average of the Ct values for Ls A-2013 and Ls A-PO
lice as calibrator sample. Expression levels (ACt) of catalase and Glp1_v2 were separately
31 subjected to analysis of variance (ANOVA) with Tukey HSD post hoc test for multiple comparisons. Group (Ls A-2013+P0, Ls V-2013 and Ls V-PO) was used as the model effect and the significance level was set to p<0.05.
Table 3: Primers used for the qPCR validation experiment. Genes: Cat, catalase; Glpl, aquaglyceroporin type 1; EF, elongation factor 1-alpha; Proh2, prohibitin-2.
Gene Primer name Primer sequence Primer Product concentration size (bp) LsCAT6 F CCACAGAACAACTTGCCAAC
_ _ Cat 150/150 nM
Ls_CAT_6 R GCCATTTCGTCCATAAATGC
Ls_ Glp1_2 F TCGGCTCCAGGAATTGTTCT
Glp1 300/300 nM
Ls_ Glp1_2 R GGTCCTAAATCTCTCGCTGGG
Ls_gEF_2 F ATGGCACGGAGACAACATGT
EF 150/150 nM
Ls_gEF_2 R CGGGCACTGTTCCAATACCT
Ls gProhib2 2 F GCTCATCACACAGCGTCAAC
Proh2 300/300 nM
Ls_gProhib2_2 R CAGCTCTTTGGGCCTCTTGT
Gene expression The catalase gene was previously found differentially expressed in fl202-sensitive and -resistant lice (Helgesen et al., 2017, supra) and its expression level has recently been introduced as H202 resistance marker in the salmon industry (Helgesen et al., 2017, supra, EP 3 164 502 B1). The present RNAseq study was performed in order to validate the use of the catalase gene expression as a resistance marker in adult females, as this developmental stage was not included in the previous study (Helgesen et al., 2017, supra).
There were significantly higher numbers of catalase transcripts in resistant lice selected by H202 (Ls V-2013 and Ls F2- H202-R) than in sensitive lice (Table 5 and Fig. 1).
However, the number of catalase transcripts in Ls V-PO parasites, which were not exposed to H202 for two years, did not differ significantly from Ls A-PO. The qPCR validation data showed a similar gene expression pattern compared to the DESeq2 analysis for 2013 and PO RNAseq samples (Figs. 1 and 3). Ls V-2013 had statistically significantly higher catalase expression than Ls A-2013 and Ls A-PO (Fig. 3). Ls V PO had a statistically similar catalase expression as Ls A-2013 and Ls A-PO. The sensitivity of the unexposed Ls V
strain was tested after completion of the RNAseq study. The EC so value for pre-adult II
females of the Ls V lab-strain was 1635 ppm, eight times higher than the Ls A strain (216 ppm) (Table 4), suggesting that Ls V -PO lice were still resistant to H202 when enrolled in the RNAseq study. In addition, more than 70% of the Ls V-PO descendants (Ls F2- H202) were unaffected at 600 ppm H202, and more than 10% at 1800 ppm (Table 1). DESeq2 analysis for Ls F2- H202-R showed that the catalase transcript had the lowest p(adj) value among the genes differentially expressed in that group of lice, and they had on average close to
Table 3: Primers used for the qPCR validation experiment. Genes: Cat, catalase; Glpl, aquaglyceroporin type 1; EF, elongation factor 1-alpha; Proh2, prohibitin-2.
Gene Primer name Primer sequence Primer Product concentration size (bp) LsCAT6 F CCACAGAACAACTTGCCAAC
_ _ Cat 150/150 nM
Ls_CAT_6 R GCCATTTCGTCCATAAATGC
Ls_ Glp1_2 F TCGGCTCCAGGAATTGTTCT
Glp1 300/300 nM
Ls_ Glp1_2 R GGTCCTAAATCTCTCGCTGGG
Ls_gEF_2 F ATGGCACGGAGACAACATGT
EF 150/150 nM
Ls_gEF_2 R CGGGCACTGTTCCAATACCT
Ls gProhib2 2 F GCTCATCACACAGCGTCAAC
Proh2 300/300 nM
Ls_gProhib2_2 R CAGCTCTTTGGGCCTCTTGT
Gene expression The catalase gene was previously found differentially expressed in fl202-sensitive and -resistant lice (Helgesen et al., 2017, supra) and its expression level has recently been introduced as H202 resistance marker in the salmon industry (Helgesen et al., 2017, supra, EP 3 164 502 B1). The present RNAseq study was performed in order to validate the use of the catalase gene expression as a resistance marker in adult females, as this developmental stage was not included in the previous study (Helgesen et al., 2017, supra).
There were significantly higher numbers of catalase transcripts in resistant lice selected by H202 (Ls V-2013 and Ls F2- H202-R) than in sensitive lice (Table 5 and Fig. 1).
However, the number of catalase transcripts in Ls V-PO parasites, which were not exposed to H202 for two years, did not differ significantly from Ls A-PO. The qPCR validation data showed a similar gene expression pattern compared to the DESeq2 analysis for 2013 and PO RNAseq samples (Figs. 1 and 3). Ls V-2013 had statistically significantly higher catalase expression than Ls A-2013 and Ls A-PO (Fig. 3). Ls V PO had a statistically similar catalase expression as Ls A-2013 and Ls A-PO. The sensitivity of the unexposed Ls V
strain was tested after completion of the RNAseq study. The EC so value for pre-adult II
females of the Ls V lab-strain was 1635 ppm, eight times higher than the Ls A strain (216 ppm) (Table 4), suggesting that Ls V -PO lice were still resistant to H202 when enrolled in the RNAseq study. In addition, more than 70% of the Ls V-PO descendants (Ls F2- H202) were unaffected at 600 ppm H202, and more than 10% at 1800 ppm (Table 1). DESeq2 analysis for Ls F2- H202-R showed that the catalase transcript had the lowest p(adj) value among the genes differentially expressed in that group of lice, and they had on average close to
32 three times higher numbers of catalase transcripts than their grandparents, Ls V-PO (Table 5.
Table 4. Bioassay results for pre-adult 11 (males and females) and young adult males exposed to H202 for 30 min. N: total number of lice used in the bioassays (all chemical concentrations together). ppm: mg L-1. EC50: concentration immobilizing 50% of the lice.
CI: confidence interval. Ls A: sensitive strain. Ls V: H202-resistant strain.
H202 exposure data:
Louse strain Year; water temperature; EC50 (ppm) (90% CI) N; doses (ppm) Ls A - Lab strain Helgesen et al. 2015, supra * 2013; 10-12 C 216 (153 - 305) Ls V
Helgesen et al. 2015, supra *
2013; 10-12 C 2127 (1253 - 3610) 2017; 10-11 C
Females: 1635 (734 -Ls V- Lab strain 25 females and 22 males 3643) M
0, 600, 1400, 2200, 3000, ales: 1795 (1095 - 2943) *Data for males and females together. 95% CI.
Table 4. Bioassay results for pre-adult 11 (males and females) and young adult males exposed to H202 for 30 min. N: total number of lice used in the bioassays (all chemical concentrations together). ppm: mg L-1. EC50: concentration immobilizing 50% of the lice.
CI: confidence interval. Ls A: sensitive strain. Ls V: H202-resistant strain.
H202 exposure data:
Louse strain Year; water temperature; EC50 (ppm) (90% CI) N; doses (ppm) Ls A - Lab strain Helgesen et al. 2015, supra * 2013; 10-12 C 216 (153 - 305) Ls V
Helgesen et al. 2015, supra *
2013; 10-12 C 2127 (1253 - 3610) 2017; 10-11 C
Females: 1635 (734 -Ls V- Lab strain 25 females and 22 males 3643) M
0, 600, 1400, 2200, 3000, ales: 1795 (1095 - 2943) *Data for males and females together. 95% CI.
33 Table 5. Gene expression data of several genes differentially expressed in the louse groups Ls 2013, PO and F2-H202. The ENSEMBL L salmonis transcriptome was used in the analysis, but the sequences of genes coding for aquaporins were replaced by GenBank entries (Stavang et al., 2015). log2FC = 1og2 fold change (up-regulation is indicated as positive values, down-regulation as negatives); p(adj) = p-value for normalized counts (a =
0.05). Statistical significance is indicated in bold. Asterisk (*) indicates no overlap in the range of normalized counts between the groups.
Average normalized counts (range) Lice Gene Ls A / F2-H202-S Ls V / F2-H202-R log2FC p(adj) group Catalase 2013 3429 (2236 -818 (675 - 1055) 2.066 <0.001*
6165) PO 954 (696 - 1326) 706 (491 - 963) -0.433 0.784 F2-H202 2072 (1580 -1161 (891- 1386) 0.836 <0.001*
2821) DNA- 2013 374 (331 - 447) 464 (390 - 505) 0.318 0.044 polymerase PO 585 (495 - 658) 930 (812 - 1134) 0.669 0.024*
F2-H202 217 (144 - 344) 320 (165 - 548) 0.561 0.045 Nesprin- 2013 3864 (3522- 5297 (4644 -0.455 <0.001 like 4290) 6116) PO 5066 (4837 - 7036 (5803 -0.474 0.034*
5304) 7547) F2-H202 3271 (2887 - 4021 (3158 -0.298 0.005 4498) 4403) NA 2013 14(8 - 17) 33 (19 - 52) 1.186 0.018*
PO 21(11 -41) 94 (57 - 164) 2.162 0.026*
F2-H202 10 (4 - 20) 21(5 - 38) 1.034 0.015 ERP29 2013 90 (77 - 102) 56 (40 - 74) -0.692 0.015*
PO 114 (96 - 128) 50 (45 - 55) -1.203 <0.001*
F2-H202 110 (76- 140) 81 (44 - 118) -0.443 0.019 G1p1_v2 2013 112 (74 - 164) 15 (10 - 26) -2.894 <0.001*
PO 77 (64 - 86) 40 (35 - 44) -0.934 0.025*
F2-ff202 197 (39 - 292) 88 (40 - 181) -1.161 0.002 Aqp12L1 2013 158 (140 - 173) 99 (73 - 152) -0.679 0.013 PO 162 (144- 192) 148 (130- 181) -0.127 0.957 F2-H202 182 (130 - 219) 141 (104 - 185) -0.370 0.010
0.05). Statistical significance is indicated in bold. Asterisk (*) indicates no overlap in the range of normalized counts between the groups.
Average normalized counts (range) Lice Gene Ls A / F2-H202-S Ls V / F2-H202-R log2FC p(adj) group Catalase 2013 3429 (2236 -818 (675 - 1055) 2.066 <0.001*
6165) PO 954 (696 - 1326) 706 (491 - 963) -0.433 0.784 F2-H202 2072 (1580 -1161 (891- 1386) 0.836 <0.001*
2821) DNA- 2013 374 (331 - 447) 464 (390 - 505) 0.318 0.044 polymerase PO 585 (495 - 658) 930 (812 - 1134) 0.669 0.024*
F2-H202 217 (144 - 344) 320 (165 - 548) 0.561 0.045 Nesprin- 2013 3864 (3522- 5297 (4644 -0.455 <0.001 like 4290) 6116) PO 5066 (4837 - 7036 (5803 -0.474 0.034*
5304) 7547) F2-H202 3271 (2887 - 4021 (3158 -0.298 0.005 4498) 4403) NA 2013 14(8 - 17) 33 (19 - 52) 1.186 0.018*
PO 21(11 -41) 94 (57 - 164) 2.162 0.026*
F2-H202 10 (4 - 20) 21(5 - 38) 1.034 0.015 ERP29 2013 90 (77 - 102) 56 (40 - 74) -0.692 0.015*
PO 114 (96 - 128) 50 (45 - 55) -1.203 <0.001*
F2-H202 110 (76- 140) 81 (44 - 118) -0.443 0.019 G1p1_v2 2013 112 (74 - 164) 15 (10 - 26) -2.894 <0.001*
PO 77 (64 - 86) 40 (35 - 44) -0.934 0.025*
F2-ff202 197 (39 - 292) 88 (40 - 181) -1.161 0.002 Aqp12L1 2013 158 (140 - 173) 99 (73 - 152) -0.679 0.013 PO 162 (144- 192) 148 (130- 181) -0.127 0.957 F2-H202 182 (130 - 219) 141 (104 - 185) -0.370 0.010
34 Aqp12L2 2013 56 (42 ¨ 75) 15 (13 ¨
20) -1.905 <0.001*
PO 29 (11 ¨46) 24 (19 ¨
30) -0.289 0.960 F2-H202 98 (69 ¨ 124) 66(31 ¨103) -0.571 0.012 G1p2 2013 20 (15 ¨ 31) 5 (0¨ 14) -1.980 0.045*
PO 17 (7 ¨ 26) 20 (16 ¨
30) 0.222 0.976 F2-H202 24 (6 ¨ 42) 11(1 ¨ 17) -1.119 0.008 G1p3_v1 2013 149 (110 ¨ 182) 297 (183 ¨
365) 0,990 <0.001*
PO 222 (185 ¨ 253) 174 (120 ¨
253) -0.351 0.855 F2-11702 134 (91 ¨ 203) 121 (82 ¨
148) -0.160 0.378 ENSEMBL/GenBank gene names for the genes: Catalase, EMLSAT00000007315; DNA-polymerase, EMLSAT00000002584; Ncsprin-likc, EMLSAT00000005972; NA (not annotated), EMLSAT00000005947; ERP29, EMLSAT00000009549; Glpl v2, KR005661.1; Aqp12L1, KR005665.1; Aqp12L2, KR005666.1; Glp2, KR005662.1:
Glp3_v1, KR005663.1.
These results may indicate that the catalase gene is induced by H202 exposure.
The induction of the catalase gene after H202 exposure was demonstrated in a penaeid shrimp (Wang ct al., 2012, supra). Thc gcnc was significantly up-rcgulatcd at 2 h aftcr injccting 0.1% H202 in the shrimp body. In addition, H202 resistance is hereditary, as demonstrated by Helgesen et al (2015, 2017, supra). The heritable factor may thus be the ability to quickly induce catalase expression. This also indicates that induction of the catalase gene can be problematic when using the expression of this gene as a 11202 resistance marker, since resistant lice not exposed to H202 may have a normal expression of this gene and could erroneously be classified as sensitive. On the other hand, after a short exposure to WO?, sensitive and resistant lice seem to be readily separable by expression of the catalase gene.
New putative molecular markers To identify further genes associated with H202 resistance, differentially expressed genes from the Ls 2013, Ls PO and Ls F2-11202 generations were compared. The resistant adult female lice that had been exposed to H202 (Ls V-2013 and Ls F2-H202-R) shared differentially expressed genes (Fig. 2). This support the hypothesis that F202 exposure could induce the expression of several genes, even within a timespan of 30 minutes. Only five genes (three up-regulated and two down-regulated in resistant lice) were differentially expressed in all three groups (Ls V-2013, Ls V-PO and Ls F2-H202¨R) (Fig. 2).
irrespective of H202 exposure. Table 5 shows the gene expression and annotation data for these genes. The log2 fold change ranged from ¨10.21 to ¨131. The three genes consistently up-regulated in presumed resistant lice were a DNA polymerase (delta subunit 3), the Nesprin-like protein and a not annotated protein (NA). Nesprin-like, also known as enaptin or synaptic nuclear envelope protein 1, is an actin-binding protein involved in the maintenance of nuclear organization and structural integrity. The two genes downregulated in resistant adult female lice were the endoplasmic reticulum resident protein 29 (ERP29) and an aquaporin protein (Glp1_v2). ERP29 plays an important role in the processing of secretory proteins within the endoplasmic reticulum.
All but Glpl_v1 and Glp3_v2 were detected in our RNAseq data. Table 5 shows the gene expression data for several aquaporins in our study. There were no statistically significant 5 differences in the expression of Bill or PripL within any of the Ls 2013, Ls PO or Ls F2-H202 groups (data not shown). However, Glpl v2 was statistically significantly down-regulated in all presumed H2O, resistant groups (Ls V-2013, Ls V-PO and Ls F2-14202-R).
The qPCR validation data showed a similar gene expression pattern compared to the DESeq2 analysis for 2013 and PO RNAseq samples (Figs. 1 and 3). Ls V-2013 and Ls V PO
10 had statistically significantly lower Glpl v2 expression than Ls A-2013 and Ls A-PO (Fig.
3). Glp 2 was significantly down-regulated in two groups, Ls V-2013 and Ls F2-H202-R, but the expression of this gene was low. Glp3_v1 was up-regulated in Ls V-2013. The unorthodox aquaporins, Aqp12L1 and Aqp12L2, were statistically significantly down-regulated in Ls V-2013 and Ls F2-H202--R groups.
15 Glp1_v2 was down-regulated in all three groups of presumed H202 resistant adult female lice, indicating a possible involvement in H202 transport: The lower the number of Glp1_v2 channels is, the less amount the exogenous H202 would enter the louse body and cause toxic effects. The downregulation of Aqp12L1 and Aqp12L2 in presumably resistant lice exposed to I-1202 may also indicate a role of these proteins as H202 channels. This goes 20 especially for Aqp12L2, with a ¨121log2 fold change and no overlap in the normalized count range in the Ls 2013 groups (Table 5). As in the case of Glps, Stavang et al. (2015), supra, also found an open pore configuration in the 3D modelling of Aqp12L2.
There was an overlap in the normalized count range for DNA-polymerase, Nesprin-like, NA, ERP29, Glp1_v2, Aqp12L1 and Aqp12L2 genes between sensitive and resistant 25 H202 lice (Table 5), although the differences were statistically significant. F2 lice is a louse population arisen from the mix of sensitive and resistant lice, with a wide range of WO, sensitivities. This gene expression overlap suggests that H2O, resistance in F2 lice comes from a number of up- and down-regulated genes combined in slightly different ways depending on each individual louse, giving to all of them the capability to survive 1800 30 ppm 1-1702. Only the expression of catalase was able to clearly separate sensitive from resistant F2 lice. As an example, the two F2-1-1202 resistant lice with high Glp1_v2 reads, are the ones with higher catalase expression, possibly suggesting a compensatory effect:
high G1p1_v2 reads could mean that more exogenous H202 would enter the louse body, needing the louse more catalase for breaking down the H202 and survive the exposure (Fig.
20) -1.905 <0.001*
PO 29 (11 ¨46) 24 (19 ¨
30) -0.289 0.960 F2-H202 98 (69 ¨ 124) 66(31 ¨103) -0.571 0.012 G1p2 2013 20 (15 ¨ 31) 5 (0¨ 14) -1.980 0.045*
PO 17 (7 ¨ 26) 20 (16 ¨
30) 0.222 0.976 F2-H202 24 (6 ¨ 42) 11(1 ¨ 17) -1.119 0.008 G1p3_v1 2013 149 (110 ¨ 182) 297 (183 ¨
365) 0,990 <0.001*
PO 222 (185 ¨ 253) 174 (120 ¨
253) -0.351 0.855 F2-11702 134 (91 ¨ 203) 121 (82 ¨
148) -0.160 0.378 ENSEMBL/GenBank gene names for the genes: Catalase, EMLSAT00000007315; DNA-polymerase, EMLSAT00000002584; Ncsprin-likc, EMLSAT00000005972; NA (not annotated), EMLSAT00000005947; ERP29, EMLSAT00000009549; Glpl v2, KR005661.1; Aqp12L1, KR005665.1; Aqp12L2, KR005666.1; Glp2, KR005662.1:
Glp3_v1, KR005663.1.
These results may indicate that the catalase gene is induced by H202 exposure.
The induction of the catalase gene after H202 exposure was demonstrated in a penaeid shrimp (Wang ct al., 2012, supra). Thc gcnc was significantly up-rcgulatcd at 2 h aftcr injccting 0.1% H202 in the shrimp body. In addition, H202 resistance is hereditary, as demonstrated by Helgesen et al (2015, 2017, supra). The heritable factor may thus be the ability to quickly induce catalase expression. This also indicates that induction of the catalase gene can be problematic when using the expression of this gene as a 11202 resistance marker, since resistant lice not exposed to H202 may have a normal expression of this gene and could erroneously be classified as sensitive. On the other hand, after a short exposure to WO?, sensitive and resistant lice seem to be readily separable by expression of the catalase gene.
New putative molecular markers To identify further genes associated with H202 resistance, differentially expressed genes from the Ls 2013, Ls PO and Ls F2-11202 generations were compared. The resistant adult female lice that had been exposed to H202 (Ls V-2013 and Ls F2-H202-R) shared differentially expressed genes (Fig. 2). This support the hypothesis that F202 exposure could induce the expression of several genes, even within a timespan of 30 minutes. Only five genes (three up-regulated and two down-regulated in resistant lice) were differentially expressed in all three groups (Ls V-2013, Ls V-PO and Ls F2-H202¨R) (Fig. 2).
irrespective of H202 exposure. Table 5 shows the gene expression and annotation data for these genes. The log2 fold change ranged from ¨10.21 to ¨131. The three genes consistently up-regulated in presumed resistant lice were a DNA polymerase (delta subunit 3), the Nesprin-like protein and a not annotated protein (NA). Nesprin-like, also known as enaptin or synaptic nuclear envelope protein 1, is an actin-binding protein involved in the maintenance of nuclear organization and structural integrity. The two genes downregulated in resistant adult female lice were the endoplasmic reticulum resident protein 29 (ERP29) and an aquaporin protein (Glp1_v2). ERP29 plays an important role in the processing of secretory proteins within the endoplasmic reticulum.
All but Glpl_v1 and Glp3_v2 were detected in our RNAseq data. Table 5 shows the gene expression data for several aquaporins in our study. There were no statistically significant 5 differences in the expression of Bill or PripL within any of the Ls 2013, Ls PO or Ls F2-H202 groups (data not shown). However, Glpl v2 was statistically significantly down-regulated in all presumed H2O, resistant groups (Ls V-2013, Ls V-PO and Ls F2-14202-R).
The qPCR validation data showed a similar gene expression pattern compared to the DESeq2 analysis for 2013 and PO RNAseq samples (Figs. 1 and 3). Ls V-2013 and Ls V PO
10 had statistically significantly lower Glpl v2 expression than Ls A-2013 and Ls A-PO (Fig.
3). Glp 2 was significantly down-regulated in two groups, Ls V-2013 and Ls F2-H202-R, but the expression of this gene was low. Glp3_v1 was up-regulated in Ls V-2013. The unorthodox aquaporins, Aqp12L1 and Aqp12L2, were statistically significantly down-regulated in Ls V-2013 and Ls F2-H202--R groups.
15 Glp1_v2 was down-regulated in all three groups of presumed H202 resistant adult female lice, indicating a possible involvement in H202 transport: The lower the number of Glp1_v2 channels is, the less amount the exogenous H202 would enter the louse body and cause toxic effects. The downregulation of Aqp12L1 and Aqp12L2 in presumably resistant lice exposed to I-1202 may also indicate a role of these proteins as H202 channels. This goes 20 especially for Aqp12L2, with a ¨121log2 fold change and no overlap in the normalized count range in the Ls 2013 groups (Table 5). As in the case of Glps, Stavang et al. (2015), supra, also found an open pore configuration in the 3D modelling of Aqp12L2.
There was an overlap in the normalized count range for DNA-polymerase, Nesprin-like, NA, ERP29, Glp1_v2, Aqp12L1 and Aqp12L2 genes between sensitive and resistant 25 H202 lice (Table 5), although the differences were statistically significant. F2 lice is a louse population arisen from the mix of sensitive and resistant lice, with a wide range of WO, sensitivities. This gene expression overlap suggests that H2O, resistance in F2 lice comes from a number of up- and down-regulated genes combined in slightly different ways depending on each individual louse, giving to all of them the capability to survive 1800 30 ppm 1-1702. Only the expression of catalase was able to clearly separate sensitive from resistant F2 lice. As an example, the two F2-1-1202 resistant lice with high Glp1_v2 reads, are the ones with higher catalase expression, possibly suggesting a compensatory effect:
high G1p1_v2 reads could mean that more exogenous H202 would enter the louse body, needing the louse more catalase for breaking down the H202 and survive the exposure (Fig.
35 1, dark grey and black triangles).
36 Table 6: Overview of sequence numbering Sequence number Description SEQ ID No. 1 DNA sequence encoding aquaglyceroporin (Glpl v2) identified in Lepeophtheirus salmonis SEQ ID No. 2 Amino acid sequence of aquaglyceroporin (Glp1_v2) encoded by SEQ ID No. 1 SEQ ID No. 3 DNA sequence encoding endoplasmic reticulum resident protein 29 (ERP29) identified in Lepeophtheirus salmonis SEQ ID No. 4 Amino acid sequence of endoplasmic reticulum resident protein 29 (ERP29) encoded by SEQ ID No. 3 SEQ ID No. 5 DNA sequence encoding DNA polymerase (delta subunit 3) identified in Lepeophtheirus salmonis SEQ ID No. 6 Amino acid sequence of DNA polymerase (delta subunit 3) encoded by SEQ Ill No. 5.
SEQ ID No. 7 DNA sequence encoding nesprin-like identified in Lepeophtheirus salmonis SEQ Ill No. 8 Amino acid sequence of nesprin-like encoded by SEQ Ill No.7 SEQ ID No. 9 DNA sequence encoding a hitherto unknown protein identified in Lepeophtheirus salmonis SEQ ID No. 10 Amino acid sequence of the protein encoded by SEQ ID No. 9 SEQ ID No. 11 DNA sequence encoding catalase of L. salrnonis SEQ ID No. 12 DNA sequence encoding catalase of C. clemensei SEQ Ill No. 13 DNA sequence encoding catalase of C.
rogercresseyi SEQ ID No. 14 DNA sequence encoding catalase of C. elongatus SEQ ID No. 15 Primer used to detect expression level of catalase (Ls_CAT_6 F) SEQ ID No. 16 Primer used to detect expression level of catalase (Ls_CAT_6 R) SEQ ID No. 17 Primer used to detect expression level of aquaglyceroporin type 1 (Ls_Glp1_2 F) SEQ Ill No. 18 Primer used to detect expression level of aquaglyceroporin type 1 (Ls_Glp1_2 R) SEQ ID No. 19 Primer used to detect expression level of elongation factor 1-alpha (Ls_gEF_2 F) SEQ ID No. 20 Primer used to detect expression level of elongation factor 1-alpha (Ls gEF 2 R) SEQ ID No. 21 Primer used to detect expression level of prohibitin-2 (Ls_gProhib2_2 F) SEQ ID No. 22 Primer used to detect expression level of prohihitin-2 (Ls_ gProhib2_2 R) SEQ ID No. 23 A revers primer of 24 nucleotides comprising the sequence CATACAAGTATAGGAACTGGCTCA wherein the primer is used for detection of a SNP in the zinc finger gene PLAGL1 from sheep (SEQ ID 12 of CN108866160 A)
SEQ ID No. 7 DNA sequence encoding nesprin-like identified in Lepeophtheirus salmonis SEQ Ill No. 8 Amino acid sequence of nesprin-like encoded by SEQ Ill No.7 SEQ ID No. 9 DNA sequence encoding a hitherto unknown protein identified in Lepeophtheirus salmonis SEQ ID No. 10 Amino acid sequence of the protein encoded by SEQ ID No. 9 SEQ ID No. 11 DNA sequence encoding catalase of L. salrnonis SEQ ID No. 12 DNA sequence encoding catalase of C. clemensei SEQ Ill No. 13 DNA sequence encoding catalase of C.
rogercresseyi SEQ ID No. 14 DNA sequence encoding catalase of C. elongatus SEQ ID No. 15 Primer used to detect expression level of catalase (Ls_CAT_6 F) SEQ ID No. 16 Primer used to detect expression level of catalase (Ls_CAT_6 R) SEQ ID No. 17 Primer used to detect expression level of aquaglyceroporin type 1 (Ls_Glp1_2 F) SEQ Ill No. 18 Primer used to detect expression level of aquaglyceroporin type 1 (Ls_Glp1_2 R) SEQ ID No. 19 Primer used to detect expression level of elongation factor 1-alpha (Ls_gEF_2 F) SEQ ID No. 20 Primer used to detect expression level of elongation factor 1-alpha (Ls gEF 2 R) SEQ ID No. 21 Primer used to detect expression level of prohibitin-2 (Ls_gProhib2_2 F) SEQ ID No. 22 Primer used to detect expression level of prohihitin-2 (Ls_ gProhib2_2 R) SEQ ID No. 23 A revers primer of 24 nucleotides comprising the sequence CATACAAGTATAGGAACTGGCTCA wherein the primer is used for detection of a SNP in the zinc finger gene PLAGL1 from sheep (SEQ ID 12 of CN108866160 A)
Claims (15)
1. Method for the detection of hydrogen peroxide resistance in one or more adult fernale sea lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clernensei, Caligus elongatus, and Caligus rogercresseyi comprising the steps of:
a) collecting onc or more adult female sea lice from infested fish or water samples;
b) isolating genomic material from the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (G1p1_v2), endoplasmic reticulurn resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
a) collecting onc or more adult female sea lice from infested fish or water samples;
b) isolating genomic material from the collected sea lice; and c) determining the expression level of at least one of the genes encoding the proteins selected from the group consisting of aquaglyceroporin (G1p1_v2), endoplasmic reticulurn resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No. 10.
2. Method according to claim 1, wherein the adult female sea lice is selected from Lepeophtheirus salmonis, Caligus clernensei, Cctligus elongtztus.
3. Mcthod according to claim 1, wherein thc sca lice is Lepeophtheirus salmonis.
4. Method according to any one of the above claims, wherein said genes encodes a protein having a sequence selected from the group consisting of SEQ ID No. 2, SEQ
ID No. 4, SEQ ID No. 6. SEQ ID No. 8, SEQ ID No. 10, or variants or fragments thereof heing at least 70 % identical with SEQ ID No. 2, SEQ ID No. 4, SEQ TD
No.
6, SEQ ID No. 8, and SEQ ID no.10, respectively.
ID No. 4, SEQ ID No. 6. SEQ ID No. 8, SEQ ID No. 10, or variants or fragments thereof heing at least 70 % identical with SEQ ID No. 2, SEQ ID No. 4, SEQ TD
No.
6, SEQ ID No. 8, and SEQ ID no.10, respectively.
5. Method according to any one of thc above claims, wherein said genes has a sequence selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5.
SEQ ID No. 7, SEQ ID No. 9, or variants or fragments thereof being at least 70 %
identical with SEQ ID No, 1, SEQ ID No, 3, SEQ ID No, 5, SEQ ID No, 7, and SEQ
ID no.9, respectively.
5.
SEQ ID No. 7, SEQ ID No. 9, or variants or fragments thereof being at least 70 %
identical with SEQ ID No, 1, SEQ ID No, 3, SEQ ID No, 5, SEQ ID No, 7, and SEQ
ID no.9, respectively.
6. Method according to any of the above claims, wherein the expression levels of at least two of thc genes encoding the protcins selected from the group consisting of aquaglyceroporin (G1p1_v2), endoplasmic reticulum resident protein 29 (ERP29), DNA polymerase (delta subunit 3), nesprin-like and the protein of SEQ ID No.
10 i determined.
10 i determined.
7. Method according to any of the above claims, wherein in addition the expression levels of a gene encoding catalase is determined.
8. Method according to claim 7, wherein the catalase gene is selected from the group consisting of SEQ ID No. 11, SEQ ID No. 12, SEQ ID No. 13, and SEQ ID No. 14 or variants or fragments thereof being at least 70 % identical with SEQ ID No.
11, SEQ
ID No. 12, SEQ ID No. 13, and SEQ ID No. 14, respectively.
11, SEQ
ID No. 12, SEQ ID No. 13, and SEQ ID No. 14, respectively.
9. Method according to any of the above claims, wherein the expression of the one or more genes in the collected sea lice or water sample is compared with the expression level of said genes in one or more non-resistant sea lice.
10. Use of one or more isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ ID No. 1, SEQ ID No. 3, SEQ ID No.
5.
SEQ ID No. 7, and SEQ ID No. 9, or a complementary oligonucleotide of SEQ ID
No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice.
5.
SEQ ID No. 7, and SEQ ID No. 9, or a complementary oligonucleotide of SEQ ID
No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively, for in vitro determination of hydrogen peroxide resistance in sea lice.
11. Use according to claim 10, wherein the one or more oligonucleotide sequence is used for determination of hydrogen peroxide resistance in sca lice selected from the group consisting of Lepeophtheirus salmonis, Caligus clemensei, Caligus elongatus, and Caligus rogercresseyi, in particular Lepeophtheirus salmonis, Caligus clemensei and Caligus elongatus and inore particular Lepeophtheirus salmonis.
12. Use according to claims 10 or claim 11, wherein the isolated oligonucleotidc sequence is selected from the group consisting of SEQ ID No. 18, SEQ ID No.
19, SEQ ID NO. 20 and SEQ ID No. 21.
19, SEQ ID NO. 20 and SEQ ID No. 21.
13. Kit for detection of hydrogen peroxide resistance in sea lice comprising one or morc isolated oligonucleotide sequence(s) comprising at least 8 contiguous nucleotides of the sequence SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ
Ill No. 9, or a complementary oligonucleotide of SEQ ID No. 1, SEQ ID No. 3, SEQ
ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively.
Ill No. 9, or a complementary oligonucleotide of SEQ ID No. 1, SEQ ID No. 3, SEQ
ID No. 5. SEQ ID No. 7, and SEQ ID No. 9, respectively.
14. A DNA molecule encoding a protein comprising an amino acid sequence selected from the group consisting of SEQ ID No. 2, SEQ ID No. 4, SEQ ID No. 6. SEQ ID
No. 8, and SEQ ID No. 10.
No. 8, and SEQ ID No. 10.
15. The DNA molecule according to claim 14, wherein the DNA molecule comprise a sequenced selected from the group consisting of SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 5, SEQ ID No. 7, and SEQ ID No. 9, or variants or fragments thereof being at least 70 % identical with the entire length of SEQ
ID
No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9.
ID
No. 1, SEQ ID No. 3, SEQ ID No. 5. SEQ ID No. 7, and SEQ ID No. 9.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20150058.4 | 2020-01-02 | ||
EP20150058 | 2020-01-02 | ||
PCT/EP2020/087625 WO2021136724A1 (en) | 2020-01-02 | 2020-12-22 | Method for detecting hydrogen peroxide resistance in crustaceans |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3162676A1 true CA3162676A1 (en) | 2021-07-08 |
Family
ID=69104300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3162676A Abandoned CA3162676A1 (en) | 2020-01-02 | 2020-12-22 | Method for detecting hydrogen peroxide resistance in crustaceans |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4085155A1 (en) |
CA (1) | CA3162676A1 (en) |
CL (1) | CL2022001804A1 (en) |
WO (1) | WO2021136724A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3030674B1 (en) | 2013-08-06 | 2021-04-14 | Patogen As | Method for detection of pyrethroid resistance in crustaceans and oligonucleotide sequences useful in detection of pyrethroid resistance. |
WO2015018863A1 (en) | 2013-08-06 | 2015-02-12 | Patogen Analyse As | Screening and identification of resistant markers in crustacean |
EP3033433B1 (en) | 2013-08-12 | 2018-10-10 | Patogen As | Detection of organophosphate resistance in crustaceans |
EP3164502B1 (en) | 2014-07-02 | 2018-12-05 | Patogen As | Method for detecting h2o2 resistance in crustaceans |
CN108866160A (en) * | 2018-06-12 | 2018-11-23 | 西北农林科技大学 | A kind of method of HRM identification animal gene insertion and deletion loci gene type |
-
2020
- 2020-12-22 WO PCT/EP2020/087625 patent/WO2021136724A1/en unknown
- 2020-12-22 EP EP20839316.5A patent/EP4085155A1/en active Pending
- 2020-12-22 CA CA3162676A patent/CA3162676A1/en not_active Abandoned
-
2022
- 2022-07-01 CL CL2022001804A patent/CL2022001804A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP4085155A1 (en) | 2022-11-09 |
CL2022001804A1 (en) | 2023-01-20 |
WO2021136724A1 (en) | 2021-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sigsgaard et al. | Population‐level inferences from environmental DNA—Current status and future perspectives | |
Llewellyn et al. | Parasitism perturbs the mucosal microbiome of Atlantic Salmon | |
Rancès et al. | The relative importance of innate immune priming in Wolbachia-mediated dengue interference | |
Craft et al. | Pyrosequencing of Mytilus galloprovincialis cDNAs: tissue-specific expression patterns | |
Tollenaere et al. | SNP design from 454 sequencing of Podosphaera plantaginis transcriptome reveals a genetically diverse pathogen metapopulation with high levels of mixed-genotype infection | |
Vences et al. | Freshwater vertebrate metabarcoding on Illumina platforms using double-indexed primers of the mitochondrial 16S rRNA gene | |
Urdaneta-Marquez et al. | A dyf-7 haplotype causes sensory neuron defects and is associated with macrocyclic lactone resistance worldwide in the nematode parasite Haemonchus contortus | |
Mathews et al. | Genetic and morphological evidence for substantial hidden biodiversity in a freshwater crayfish species complex | |
Islam et al. | Randomly amplified polymorphic DNA analysis of four different populations of the Indian major carp, Labeo rohita (Hamilton) | |
Liu et al. | Fine mapping QTL for resistance to VNN disease using a high-density linkage map in Asian seabass | |
Steinauer et al. | Introgressive hybridization of human and rodent schistosome parasites in western Kenya | |
Milan et al. | Transcriptomic resources for environmental risk assessment: a case study in the Venice lagoon | |
Wang et al. | Comparative analysis of eight DNA extraction methods for molecular research in mealybugs | |
Sargison et al. | Faecal egg counts and nemabiome metabarcoding highlight the genomic complexity of equine cyathostomin communities and provide insight into their dynamics in a Scottish native pony herd | |
Halbert et al. | High cryptic diversity across the global range of the migratory planktonic copepods Pleuromamma piseki and P. gracilis | |
Poley et al. | Cypermethrin exposure induces metabolic and stress-related gene expression in copepodid salmon lice (Lepeophtheirus salmonis) | |
Narum et al. | Candidate genetic markers associated with anadromy in Oncorhynchus mykiss of the Klickitat River | |
Rašić et al. | The queenslandensis and the type form of the dengue fever mosquito (Aedes aegypti L.) are genomically indistinguishable | |
Holborn et al. | Genome wide analysis of infectious salmon anemia resistance in commercial Saint John River Atlantic salmon | |
Nieves‐Colón et al. | Ancient DNA analysis of archaeological remains | |
JP5919257B2 (en) | Macrocyclic lactone resistance marker for Dirofilaria immitis | |
Agusti-Ridaura et al. | Candidate genes for monitoring hydrogen peroxide resistance in the salmon louse, Lepeophtheirus salmonis | |
Laoprom et al. | Microsatellite loci in the carcinogenic liver fluke, Opisthorchis viverrini and their application as population genetic markers | |
CA2913596C (en) | Markers to predict macrocyclic lactone resistance in dirofilaria immitis, the causative agent of heartworm disease | |
CA3162676A1 (en) | Method for detecting hydrogen peroxide resistance in crustaceans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20220929 |
|
EEER | Examination request |
Effective date: 20220929 |
|
EEER | Examination request |
Effective date: 20220929 |
|
FZDE | Discontinued |
Effective date: 20240116 |